halmanac.blob.core.windows.nethalmanac.blob.core.windows.net/reports/sum_esrd_profile... · 2020....
TRANSCRIPT
142821
, IL
12/31/2017 133 Days *Settled
Balance Sheet
-3,478,005
Income Statement
2,476,525
0
-1,001,480
-30,208
-273,982
1,305,671
1,001,481 -28.7%
12.6%
(5.0)
292.0
3.3%
21.3%
Key Performanace Ind.
115.1
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 423,187
100.0%
188.6%
-88.6%
0.0%
0.0%
-88.6%
Current Assets
Fixed Assets
423,187
797,921
-374,734
0
0
(374,734)
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142822
, IL
12/31/2017 112 Days Settled
Balance Sheet
-131,017
Income Statement
-48,434
-180
-179,631
-2,482
953
-178,104
-179,633 100.0%
241.7%
(1.0)
100.9
2.3%
28.9%
Key Performanace Ind.
52.8
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
3.0%2,350Contract Allowance
Total Charges 79,600
97.0%
330.6%
-230.6%
0.0%
0.0%
-230.6%
Current Assets
Fixed Assets
77,250
255,354
-178,104
0
0
(178,104)
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 1
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142824
, IL
12/31/2017 56 Days *Settled
Balance Sheet
3,253
Income Statement
3,302
7,000
13,555
89,977
0
-76,422
13,555 144.7%
254.0%
0.0
159.6
2.7%
35.5%
Key Performanace Ind.
0.0
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 703
100.0%
15,825.6%
-15,725.6
%
0.0%
0.0%
-15,725.6
%
Current Assets
Fixed Assets
703
111,254
-110,551
0
0
(110,551)
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 2
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142676
AFFILIATED DIALYSIS CENTERS LLC
715 LAKE STREET SUITE 318
OAK PARK, IL 60301
COOK
CGS (KENTUCKY)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
4,121,824
Income Statement
515,533
54,268
4,691,625
592,545
241,834
3,857,246
4,691,625 18.0%
2.4%
18.5
(22.8)
5.3%
37.2%
Key Performanace Ind.
7.0
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 6,643,910
100.0%
89.6%
10.4%
0.0%
0.0%
10.4%
Current Assets
Fixed Assets
6,643,910
5,950,486
693,424
0
0
693,424
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142752
AFFILIATED DIALYSIS OF GLEN ELLYN
800 ROOSEVELT RD
GLEN ELLYN, IL 60137
DUPAGE
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
2,488,339
Income Statement
465,983
0
2,954,322
983,671
76,700
1,893,951
2,954,322 38.0%
1.6%
18.0
(24.5)
4.6%
32.4%
Key Performanace Ind.
2.5
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 5,757,848
100.0%
87.5%
12.5%
0.0%
0.0%
12.5%
Current Assets
Fixed Assets
5,757,848
5,038,433
719,415
0
0
719,415
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 3
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142773
AFFILIATED DIALYSIS OF JOLIET, LLC
1352 HOUBOLT RD
JOLIET, IL 60431
WILL
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
157,507
Income Statement
110,781
28,418
296,706
114,476
59,312
122,918
296,706 145.2%
13.2%
34.0
10.8
6.3%
26.2%
Key Performanace Ind.
1.4
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 835,512
100.0%
78.6%
21.4%
0.0%
0.0%
21.4%
Current Assets
Fixed Assets
835,512
657,094
178,418
0
0
178,418
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142683
AFFILIATED HOME DIALYSIS
2462 WASHINGTON ROAD
WASHINGTON, IL 61571
TAZEWELL
NGS (IL)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
1,592,240
Income Statement
637,164
0
2,229,404
626,164
748,345
854,895
2,229,404 -15.9%
0.4%
49.6
(128.1)
3.4%
30.4%
Key Performanace Ind.
2.5
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 1,084,244
100.0%
112.5%
-12.5%
0.0%
0.0%
-12.5%
Current Assets
Fixed Assets
1,084,244
1,220,175
-135,931
0
0
(135,931)
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 4
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142699
AFFILIATED HOME DIALYSIS
1014 BONAVENTURE DR
ELK GROVE VILLAGE, IL 60007
COOK
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
1,592,240
Income Statement
637,164
0
2,229,404
626,164
748,345
854,895
2,229,404 54.7%
1.5%
15.9
(32.5)
2.2%
21.6%
Key Performanace Ind.
2.5
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 4,266,803
100.0%
89.0%
11.0%
0.0%
0.0%
11.0%
Current Assets
Fixed Assets
4,266,803
3,799,536
467,267
0
0
467,267
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142808
ALSIP HOME TRAINING
11500 S PULASKI RD
ALSIP, IL 60803
COOK
DUMMY FOR MEDICAID HHA
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
198,925
Income Statement
658,177
0
857,102
20,644
35,463
800,995
857,102 -31.1%
13.3%
5.5
215.7
3.7%
33.6%
Key Performanace Ind.
9.6
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
1.3%3,227Contract Allowance
Total Charges 253,709
98.7%
210.5%
-110.5%
11.0%
0.0%
-99.5%
Current Assets
Fixed Assets
250,482
527,210
-276,728
27,558
0
(249,170)
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 5
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142820
ANGEL CARE CENTER, LLC
14 S WALNUT STREET
PINCKNEYVILLE, IL 62274
PERRY
DUMMY FOR MEDICAID HHA
12/31/2017 118 Days *Settled
For Profit
End Stage Renal Disease
Balance Sheet
315,939
Income Statement
225,674
0
541,613
339,580
0
202,033
541,613 20.5%
1.3%
4.9
13.0
4.9%
37.0%
Key Performanace Ind.
0.9
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 263,979
100.0%
84.3%
15.7%
0.0%
0.0%
15.7%
Current Assets
Fixed Assets
263,979
222,543
41,436
0
0
41,436
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142664
ARA CRYSTAL LAKE DIALYSIS
6298 NORTHWEST HIGHWAY
CRYSTAL LAKE, IL 60014
MCHENRY
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
442,212
Income Statement
133,868
8,757
584,837
200,954
0
383,883
584,837 251.3%
7.2%
24.6
24.9
10.8%
33.8%
Key Performanace Ind.
2.2
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-10.0%-226,036Contract Allowance
Total Charges 2,249,866
110.0%
61.0%
39.0%
0.0%
0.0%
39.0%
Current Assets
Fixed Assets
2,475,902
1,511,162
964,740
0
0
964,740
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 6
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142737
ARA MCHENRY DIALYSIS LLC
4209 WEST SHAMROCK LANE
MCHENRY, IL 60050
MCHENRY
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
199,527
Income Statement
362,987
40,451
602,965
228,104
0
374,861
602,965 658.8%
13.7%
23.2
1.7
10.5%
30.6%
Key Performanace Ind.
0.9
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-32.1%-926,249Contract Allowance
Total Charges 2,883,287
132.1%
35.2%
64.8%
0.0%
0.0%
64.8%
Current Assets
Fixed Assets
3,809,536
1,339,931
2,469,605
0
0
2,469,605
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142626
ARLINGTON HEIGHTS PD
17 WEST GOLF ROAD
ARLINGTON HEIGHTS, IL 60005
COOK
FIRST COAST (FLORIDA)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
1,948,355
Income Statement
6,641
0
1,954,996
260,418
0
1,694,577
1,954,995 10.8%
25.9%
0.0
46.9
4.5%
38.3%
Key Performanace Ind.
7.5
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
1.0%5,584Contract Allowance
Total Charges 541,237
99.0%
66.0%
34.0%
0.0%
0.0%
34.0%
Current Assets
Fixed Assets
535,653
353,461
182,192
96
0
182,288
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 7
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142628
ARLINGTON HEIGHTS RENAL CENTER
17 WEST GOLF ROAD
ARLINGTON HEIGHTS, IL 60005
COOK
BLUE CROSS (FLORIDA)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
4,638,402
Income Statement
237,364
-17,290
4,858,476
628,625
6,695
4,223,154
4,858,474 14.6%
14.0%
7.7
102.7
5.7%
33.3%
Key Performanace Ind.
7.4
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-0.3%-10,911Contract Allowance
Total Charges 3,337,144
100.3%
81.6%
18.4%
0.0%
0.0%
18.4%
Current Assets
Fixed Assets
3,348,055
2,732,068
615,987
560
0
616,547
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142515
AURORA DIALYSIS CENTER
455 MERCY LANE
AURORA, IL 60505
KANE
BLUE CROSS (TEXAS)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
35,502,266
Income Statement
219,297
0
35,721,563
-511,559
-4,569,866
-30,640,135
-35,721,560 -15.8%
45.1%
(33.1)
89.0
11.7%
37.9%
Key Performanace Ind.
(69.4)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 10,491,935
100.0%
53.7%
46.3%
0.0%
0.0%
46.3%
Current Assets
Fixed Assets
10,491,935
5,638,304
4,853,631
1
0
4,853,632
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 8
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142653
AUSTIN COMMUNITY KIDNEY CENTER
4800 WEST CHICAGO AVENUE, STE 2A
CHICAGO, IL 60651
COOK
BLUE CROSS (TEXAS)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
-478,835
Income Statement
118,070
0
-360,765
-352,420
-406,215
1,119,400
360,765 41.2%
15.2%
(63.1)
140.8
8.2%
38.2%
Key Performanace Ind.
1.4
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 2,500,566
100.0%
81.5%
18.5%
0.0%
0.0%
18.5%
Current Assets
Fixed Assets
2,500,566
2,039,019
461,547
1
0
461,548
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142781
AVANTUS HOME THERAPY
901 WEST UNIVERSITY AVE, SUITE 302
URBANA, IL 61801
CHAMPAIGN
DUMMY FOR MEDICAID HHA
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
10,188,997
Income Statement
688,359
0
10,877,356
-29,766
-216,898
-10,630,692
-10,877,356 -3.1%
17.1%
(11.3)
25.5
5.2%
16.3%
Key Performanace Ind.
(342.3)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 1,291,923
100.0%
74.7%
25.3%
0.0%
0.0%
25.3%
Current Assets
Fixed Assets
1,291,923
964,886
327,037
0
0
327,037
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 9
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142736
BARRINGTON CREEK DIALYSIS
28160 W NORTHWEST HWY
LK BARRINGTON, IL 60010
LAKE
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
1,498,206
Income Statement
725,435
0
2,223,641
1,330,276
217,088
676,276
2,223,640 42.6%
18.1%
5.3
86.6
3.3%
27.1%
Key Performanace Ind.
1.1
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-16.9%-361,799Contract Allowance
Total Charges 2,147,136
116.9%
77.9%
22.1%
-10.7%
0.0%
11.5%
Current Assets
Fixed Assets
2,508,935
1,953,360
555,575
-267,458
0
288,117
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142795
BELVIDERE DIALYSIS
1751 HENRY LUCKLOW LANE
BELVIDERE, IL 61008
BOONE
DUMMY FOR MEDICAID HHA
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
1,569,121
Income Statement
2,387,909
0
3,957,030
472,914
1,270,723
2,213,394
3,957,031 6.9%
6.8%
6.6
19.3
4.3%
27.6%
Key Performanace Ind.
3.3
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-79.0%-778,670Contract Allowance
Total Charges 985,934
179.0%
85.5%
14.5%
-5.9%
0.0%
8.6%
Current Assets
Fixed Assets
1,764,604
1,508,217
256,387
-104,487
0
151,900
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 10
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142638
BEVERLY DIALYSIS
8109 SOUTH WESTERN AVENUE
CHICAGO, IL 60620
COOK
NGS (IL)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
11,785,475
Income Statement
548,238
4,646,457
16,980,170
1,930,532
25,078
15,024,559
16,980,169 11.3%
16.5%
3.2
192.4
4.6%
26.9%
Key Performanace Ind.
6.1
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-22.8%-1,259,125Contract Allowance
Total Charges 5,520,228
122.8%
75.3%
24.7%
0.3%
0.0%
25.0%
Current Assets
Fixed Assets
6,779,353
5,105,847
1,673,506
21,462
0
1,694,968
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142712
BIG OAKS DIALYSIS
5623 W TOUHY AVE
NILES, IL 60714
COOK
DUMMY FOR MEDICAID HHA
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
1,713,636
Income Statement
230,118
0
1,943,754
986,421
47,177
910,156
1,943,754 86.6%
17.8%
4.2
138.3
4.3%
35.5%
Key Performanace Ind.
1.7
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-2.8%-81,036Contract Allowance
Total Charges 2,880,752
102.8%
73.5%
26.5%
0.1%
0.0%
26.6%
Current Assets
Fixed Assets
2,961,788
2,177,159
784,629
3,912
0
788,541
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 11
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142514
BIO-MEDICAL APPLICATIONS OF ILLINOIS, INC
1425 E MAIN ST
CARBONDALE, IL 62901
JACKSON
BLUE CROSS (TEXAS)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
35,790,348
Income Statement
1,329,334
0
37,119,682
-266,628
-1,096,890
-35,756,164
-37,119,682 -1.1%
21.8%
(26.1)
62.5
8.0%
32.0%
Key Performanace Ind.
(134.2)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 4,136,415
100.0%
90.1%
9.9%
0.0%
0.0%
9.9%
Current Assets
Fixed Assets
4,136,415
3,728,884
407,531
-1
0
407,530
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142535
BIO-MEDICAL APPLICATIONS OF ILLINOIS, INC
7 PROFESSIONAL DRIVE
ALTON, IL 62002
MADISON
BLUE CROSS (MISSOURI)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
10,440,577
Income Statement
1,095,697
0
11,536,274
-324,717
-936,429
-10,275,128
-11,536,274 -16.9%
20.7%
(35.8)
35.2
9.7%
35.1%
Key Performanace Ind.
(32.2)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 5,049,001
100.0%
65.5%
34.5%
0.0%
0.0%
34.5%
Current Assets
Fixed Assets
5,049,001
3,309,255
1,739,746
1,354
0
1,741,100
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 12
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142573
BIO-MEDICAL APPLICATIONS OF ILLINOIS, INC
275 SMALL STREET
HARRISBURG, IL 62946
SALINE
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
9,192,591
Income Statement
507,933
833
9,701,357
-302,474
-99,064
-9,299,819
-9,701,357 -2.6%
12.4%
(41.9)
60.1
8.6%
32.3%
Key Performanace Ind.
(30.4)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 2,877,726
100.0%
91.7%
8.3%
0.0%
0.0%
8.3%
Current Assets
Fixed Assets
2,877,726
2,637,928
239,798
0
0
239,798
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142817
CALUMET CITY DIALYSIS
1200 SIBLEY BLVD
CALUMET CITY, IL 60409
COOK
DUMMY FOR MEDICAID HHA
12/31/2017 182 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
-523,790
Income Statement
95,264
0
-428,526
-883
-49,833
-377,809
-428,525 100.0%
77.5%
(0.5)
457.4
4.0%
30.8%
Key Performanace Ind.
593.2
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
6.6%14,975Contract Allowance
Total Charges 225,280
93.4%
279.6%
-179.6%
0.0%
0.0%
-179.6%
Current Assets
Fixed Assets
210,305
588,113
-377,808
0
0
(377,808)
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 13
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142598
CARPENTERSVILLE DIALYSIS
2203 RANDALL ROAD
CARPENTERSVILLE, IL 60110
KANE
DUMMY FOR MEDICAID HHA
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
1,633,031
Income Statement
892,406
6,218,329
8,743,766
1,749,032
5,985
6,988,748
8,743,765 28.7%
19.2%
9.3
120.5
5.1%
31.5%
Key Performanace Ind.
0.9
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-0.1%-5,111Contract Allowance
Total Charges 5,293,715
100.1%
62.6%
37.4%
0.4%
0.0%
37.8%
Current Assets
Fixed Assets
5,298,826
3,315,137
1,983,689
20,122
0
2,003,811
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142663
CENTER FOR RENAL REPLACEMENT LLC
7301 NORTH LINCOLN AVE SUITE 205
LINCOLNWOOD, IL 60712
COOK
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
-48,413
Income Statement
721,439
27,953
700,979
-554,824
810,856
444,947
700,979 -55.4%
10.3%
(96.0)
(8.8)
3.7%
44.7%
Key Performanace Ind.
0.1
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 2,015,252
100.0%
112.2%
-12.2%
0.0%
0.0%
-12.2%
Current Assets
Fixed Assets
2,015,252
2,261,742
-246,490
0
0
(246,490)
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 14
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142588
CHAMPAIGN URBANA DIALYSIS CENTER
1405 WEST PARK STREET
URBANA, IL 61801
CHAMPAIGN
BLUE CROSS (TEXAS)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
12,924,257
Income Statement
356,234
3,978,274
17,258,765
-77,832
-1,300,329
-15,880,601
-17,258,762 0.9%
35.4%
(6.0)
36.8
5.1%
46.2%
Key Performanace Ind.
(166.1)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 4,587,423
100.0%
103.1%
-3.1%
0.0%
0.0%
-3.1%
Current Assets
Fixed Assets
4,587,423
4,730,366
-142,943
1
0
(142,942)
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142635
CHICAGO HEIGHTS DIALYSIS
177 B WEST JOE ORR ROAD
CHICAGO HEIGHTS, IL 60411
COOK
BLUE CROSS (TEXAS)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
2,119,481
Income Statement
62,198
2,289,702
4,471,381
596,470
26,754
3,848,158
4,471,382 14.4%
14.5%
5.2
169.0
5.8%
31.7%
Key Performanace Ind.
3.6
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-1.7%-65,808Contract Allowance
Total Charges 3,872,864
101.7%
82.1%
17.9%
-3.8%
0.0%
14.1%
Current Assets
Fixed Assets
3,938,672
3,233,101
705,571
-151,618
0
553,953
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 15
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142793
CHICAGO RIDGE DIALYSIS
10511 S HARLEM AVE
CHICAGO RIDGE, IL 60415
COOK
DUMMY FOR MEDICAID HHA
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
1,787,084
Income Statement
1,532,012
0
3,319,096
840,556
153,883
2,324,657
3,319,096 -2.4%
25.9%
2.6
169.3
3.7%
27.8%
Key Performanace Ind.
2.1
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-17.2%-399,735Contract Allowance
Total Charges 2,330,350
117.2%
102.1%
-2.1%
0.0%
0.0%
-2.1%
Current Assets
Fixed Assets
2,730,085
2,787,057
-56,972
21
0
(56,951)
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142540
CIRCLE MEDICAL MANAGEMENT
1426 W WASHINGTON BLVD
CHICAGO, IL 60607
COOK
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
3,194,706
Income Statement
930,028
0
4,124,734
1,196,164
0
2,928,570
4,124,734 230.3%
4.9%
24.7
246.7
5.3%
42.6%
Key Performanace Ind.
2.7
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
74.9%33,185,956Contract Allowance
Total Charges 44,327,419
25.1%
76.5%
23.5%
37.0%
0.0%
60.5%
Current Assets
Fixed Assets
11,141,463
8,518,804
2,622,659
4,122,987
0
6,745,646
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 16
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142804
COAL CITY HOME TRAINING
993 E DIVISION ST, SUITE A
COAL CITY, IL 60416
GRUNDY
NGS (IL)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
-1,110,018
Income Statement
263,450
0
-846,568
198
4,958
-851,724
-846,568 34.1%
25.6%
0.2
122.0
0.9%
20.4%
Key Performanace Ind.
(5,606.2)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
1.9%686Contract Allowance
Total Charges 36,794
98.1%
903.8%
-803.8%
0.0%
0.0%
-803.8%
Current Assets
Fixed Assets
36,108
326,361
-290,253
0
0
(290,253)
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142715
COBBLESTONE DIALYSIS
836 DUNDEE AVE
ELGIN, IL 60120
KANE
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
472,236
Income Statement
1,019,354
5,511,070
7,002,660
1,556,226
414,838
5,031,596
7,002,660 24.8%
12.9%
5.5
120.0
5.0%
29.5%
Key Performanace Ind.
0.3
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-3.9%-185,867Contract Allowance
Total Charges 4,725,443
103.9%
74.6%
25.4%
0.0%
0.0%
25.4%
Current Assets
Fixed Assets
4,911,310
3,664,471
1,246,839
1,469
0
1,248,308
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 17
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142575
COUNTRY HILLS DIALYSIS
4215 W 167TH ST
COUNTRY CLUB HILLS, IL 60478
COOK
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
10,235,671
Income Statement
2,898,613
-27,182
13,107,102
1,767,580
2,048,115
9,291,408
13,107,103 6.1%
14.6%
3.5
131.8
5.9%
25.4%
Key Performanace Ind.
5.8
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
1.6%76,193Contract Allowance
Total Charges 4,809,583
98.4%
88.1%
11.9%
0.2%
0.0%
12.1%
Current Assets
Fixed Assets
4,733,390
4,169,816
563,574
7,225
0
570,799
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142748
CRIMSON RIDGE HOME TRAINING
2540 HAUSER ROSS DR, SUITE 200
SYCAMORE, IL 60178
DEKALB
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
4,670,637
Income Statement
178,361
0
4,848,998
859,966
23,420
3,965,611
4,848,997 9.5%
12.6%
4.9
124.0
3.2%
19.4%
Key Performanace Ind.
5.4
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.6%10,915Contract Allowance
Total Charges 1,906,964
99.4%
60.5%
39.5%
-19.6%
0.0%
19.9%
Current Assets
Fixed Assets
1,896,049
1,148,040
748,009
-371,534
0
376,475
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 18
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142716
CRYSTAL SPRINGS DIALYSIS
720 COG CIRCLE, SUITE A
CRYSTAL LAKE, IL 60014
MCHENRY
NGS (IL)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
6,723,333
Income Statement
390,759
58,519
7,172,611
1,046,221
82,598
6,043,793
7,172,612 18.9%
16.4%
5.8
172.7
5.1%
32.5%
Key Performanace Ind.
6.4
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
14.4%641,554Contract Allowance
Total Charges 4,456,190
85.6%
70.0%
30.0%
0.0%
0.0%
30.0%
Current Assets
Fixed Assets
3,814,636
2,671,932
1,142,704
984
0
1,143,688
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142537
DA VITA GRANITE CITY DIALYSIS CENTER
#9 AMERICAN VILLAGE SHOPPING CENTER
GRANITE CITY, IL 62040
MADISON
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
11,379,865
Income Statement
315,633
0
11,695,498
557,313
129,875
11,008,310
11,695,498 7.4%
10.1%
3.2
147.8
4.9%
26.0%
Key Performanace Ind.
20.4
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-4.2%-179,037Contract Allowance
Total Charges 4,294,428
104.2%
82.0%
18.0%
0.2%
0.0%
18.2%
Current Assets
Fixed Assets
4,473,465
3,668,723
804,742
9,473
0
814,215
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 19
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142527
DA VITA METRO EAST
5105 WEST MAIN STREET
BELLEVILLE, IL 62223
SAINT CLAIR
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
27,905,269
Income Statement
714,595
6,350,808
34,970,672
2,744,696
142,896
32,083,081
34,970,673 8.4%
14.0%
3.4
82.9
6.0%
27.6%
Key Performanace Ind.
10.2
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-6.7%-671,178Contract Allowance
Total Charges 10,001,196
106.7%
74.8%
25.2%
0.2%
0.0%
25.4%
Current Assets
Fixed Assets
10,672,374
7,979,195
2,693,179
16,317
0
2,709,496
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142625
DANVILLE DIALYSIS SERVICES LLC
910 WEST CLAY STREET
DANVILLE, IL 61832
VERMILION
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
470,553
Income Statement
1,404
130
472,087
1,303
0
470,784
472,087 -209.1%
6.4%
0.1
53.0
6.7%
37.3%
Key Performanace Ind.
361.1
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
20.4%831,315Contract Allowance
Total Charges 4,072,824
79.6%
130.4%
-30.4%
0.0%
0.0%
-30.4%
Current Assets
Fixed Assets
3,241,509
4,225,836
-984,327
0
0
(984,327)
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 20
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142734
DANVILLE HOME TRAINING
3 POLAND RD
DANVILLE, IL 61834
VERMILION
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
1,614,343
Income Statement
67,707
0
1,682,050
134,064
2,751
1,545,236
1,682,051 22.1%
9.0%
0.6
56.8
2.3%
20.7%
Key Performanace Ind.
12.0
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-5.3%-75,834Contract Allowance
Total Charges 1,429,921
105.3%
77.3%
22.7%
0.0%
0.0%
22.7%
Current Assets
Fixed Assets
1,505,755
1,164,193
341,562
34
0
341,596
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142569
DIALYSIS CENTERS OF AMERICA IL
1717 S WABASH AVE
CHICAGO, IL 60616
COOK
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
-92,031,030
Income Statement
164,897
14,500
-91,851,633
-403,439
-1,491,234
93,746,307
91,851,634 2.1%
26.7%
(39.9)
47.6
8.3%
35.5%
Key Performanace Ind.
228.1
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 5,690,560
100.0%
64.9%
35.1%
0.0%
0.0%
35.1%
Current Assets
Fixed Assets
5,690,560
3,693,359
1,997,201
-1
0
1,997,200
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 21
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142571
DIALYSIS CENTERS OF AMERICA ILLINOIS, INC
3521 VETERANS DRIVE
PEKIN, IL 61554
TAZEWELL
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
9,971,388
Income Statement
962,450
0
10,933,838
-58,744
-530,836
-10,344,260
-10,933,840 -7.8%
12.8%
(13.3)
67.8
6.7%
33.0%
Key Performanace Ind.
(169.7)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 2,426,079
100.0%
66.6%
33.4%
0.0%
0.0%
33.4%
Current Assets
Fixed Assets
2,426,079
1,616,341
809,738
-3
0
809,735
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142655
DIRECT DIALYSIS
14255 SOUTH CICERO AVENUE
CRESTWOOD, IL 60455
COOK
DUMMY FOR MEDICAID HHA
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
6,774,769
Income Statement
2,427,258
21,604
9,223,631
5,219,427
850,000
3,154,204
9,223,631 76.9%
6.8%
15.9
59.4
9.9%
30.2%
Key Performanace Ind.
1.3
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
41.5%15,648,750Contract Allowance
Total Charges 37,748,040
58.5%
89.3%
10.7%
0.2%
0.0%
11.0%
Current Assets
Fixed Assets
22,099,290
19,729,101
2,370,189
54,680
0
2,424,869
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 22
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142651
DIXON KIDNEY CENTER
1131 N GALENA AVE
DIXON, IL 61021
LEE
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
3,506,798
Income Statement
985,097
0
4,491,895
628,680
742,879
3,120,334
4,491,893 17.6%
5.5%
3.8
433.2
4.1%
29.4%
Key Performanace Ind.
5.6
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-10.1%-250,942Contract Allowance
Total Charges 2,496,443
110.1%
80.1%
19.9%
0.0%
0.0%
20.0%
Current Assets
Fixed Assets
2,747,385
2,200,044
547,341
1,199
0
548,540
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142503
DOWNERS GROVE DIALYSIS CENTER
3825 HIGHLAND AVENUE SUITE 102
DOWNERS GROVE, IL 60515
DUPAGE
BLUE CROSS (TEXAS)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
17,868,357
Income Statement
608,256
8,288
18,484,901
-117,618
-1,991,050
-16,376,232
-18,484,900 -9.1%
25.6%
(16.1)
37.4
7.8%
35.7%
Key Performanace Ind.
(151.9)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 4,160,912
100.0%
64.1%
35.9%
0.0%
0.0%
35.9%
Current Assets
Fixed Assets
4,160,912
2,665,444
1,495,468
1
0
1,495,469
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 23
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142747
DRIFTWOOD DIALYSIS
1808 S WEST AVE
FREEPORT, IL 61032
STEPHENSON
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
774,323
Income Statement
692,478
0
1,466,801
295,434
93,663
1,077,705
1,466,802 -2.7%
13.9%
4.2
80.9
4.2%
29.2%
Key Performanace Ind.
2.6
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-2.8%-55,477Contract Allowance
Total Charges 1,962,212
102.8%
101.6%
-1.6%
0.2%
0.0%
-1.4%
Current Assets
Fixed Assets
2,017,689
2,049,865
-32,176
3,097
0
(29,079)
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142650
DSI RENAL BUFFALO GROVE, LLC
1291 W DUNDEE RD
BUFFALO GROVE, IL 60089
LAKE
BLUE CROSS (FLORIDA)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
7,754,093
Income Statement
184,286
-1,741,738
6,196,641
1,250,046
31,693
4,914,902
6,196,641 16.9%
12.6%
4.6
149.7
4.5%
31.9%
Key Performanace Ind.
6.2
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
1.9%66,722Contract Allowance
Total Charges 3,456,631
98.1%
75.6%
24.4%
0.1%
0.0%
24.5%
Current Assets
Fixed Assets
3,389,909
2,561,688
828,221
1,799
0
830,020
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 24
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142505
DSI RENAL, INC
1101 S CANAL ST STE 005
CHICAGO, IL 60609
COOK
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
9,501,581
Income Statement
1,789,933
-14,825
11,276,689
1,487,587
64,419
9,724,682
11,276,688 1.9%
20.3%
6.2
267.7
5.1%
26.2%
Key Performanace Ind.
6.4
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
4.7%280,550Contract Allowance
Total Charges 6,015,179
95.3%
97.5%
2.5%
0.8%
0.0%
3.3%
Current Assets
Fixed Assets
5,734,629
5,589,799
144,830
44,224
0
189,054
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142518
DSI SCOTTSDALE RENAL CENTER
4651 W 79TH ST UNIT 100
CHICAGO, IL 60652
COOK
BLUE CROSS (FLORIDA)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
1,538,354
Income Statement
468,166
-402,752
1,603,768
-23,680,024
-2,052,506
27,336,298
1,603,768 17.8%
19.2%
19.1
64.0
6.3%
35.4%
Key Performanace Ind.
(0.1)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
96.0%231,764,694Contract Allowance
Total Charges 241,382,193
4.0%
49.4%
50.6%
-0.1%
0.0%
50.5%
Current Assets
Fixed Assets
9,617,499
4,752,644
4,864,855
-11,754
0
4,853,101
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 25
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142544
DSI SOUTH HOLLAND RENAL CENTER
16136 SOUTH PARK AVENUE
SOUTH HOLLAND, IL 60473
COOK
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
15,121,165
Income Statement
1,712,447
-8,786
16,824,826
1,344,752
166,639
15,313,434
16,824,825 6.6%
11.7%
4.0
119.4
6.4%
31.4%
Key Performanace Ind.
11.2
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.4%24,376Contract Allowance
Total Charges 5,970,998
99.6%
83.1%
16.9%
0.1%
0.0%
17.0%
Current Assets
Fixed Assets
5,946,622
4,939,488
1,007,134
6,243
0
1,013,377
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142567
DSI WAUKEGAN HOME RENAL CENTER
3350 GRAND AVE, SUITE 101
WAUKEGAN, IL 60085
LAKE
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
187,770
Income Statement
16,359
0
204,129
78,763
34,939
90,429
204,131 0.5%
62.9%
0.0
107.6
1.8%
29.3%
Key Performanace Ind.
2.4
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-6.5%-15,673Contract Allowance
Total Charges 240,006
106.5%
99.8%
0.2%
0.0%
0.0%
0.2%
Current Assets
Fixed Assets
255,679
255,283
396
13
0
409
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 26
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142577
DSI WAUKEGAN RENAL CENTER
3350 GRAND AVE, SUITE 100
WAUKEGAN, IL 60085
LAKE
FIRST COAST (FLORIDA)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
12,478,598
Income Statement
1,283,989
17,351
13,779,938
2,208,549
193,270
11,378,119
13,779,938 18.9%
22.8%
5.7
118.0
5.6%
31.1%
Key Performanace Ind.
5.7
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-0.1%-8,959Contract Allowance
Total Charges 7,519,847
100.1%
70.7%
29.3%
-0.7%
0.0%
28.6%
Current Assets
Fixed Assets
7,528,806
5,322,465
2,206,341
-51,437
0
2,154,904
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142558
DVA RENAL HEALTHCARE INC
124 REGENCY PARK DRIVE, SUITE 1
O FALLON, IL 62269
SAINT CLAIR
BLUE CROSS (GEORGIA)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
20,479,251
Income Statement
874,872
-8,292,768
13,061,355
-727,473
-1,572,078
-10,761,805
-13,061,356 -24.6%
17.9%
(61.1)
42.7
8.6%
32.9%
Key Performanace Ind.
(28.2)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 6,987,603
100.0%
62.2%
37.8%
0.0%
0.0%
37.8%
Current Assets
Fixed Assets
6,987,603
4,342,944
2,644,659
0
0
2,644,659
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 27
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142619
DVA RENAL HEALTHCARE INC DBA ALTON DIALYSIS
309 HOMER ADAMS PARKWAY
ALTON, IL 62002
MADISON
BLUE CROSS (GEORGIA)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
12,908,535
Income Statement
1,516,230
0
14,424,765
945,692
98,435
13,380,636
14,424,763 5.1%
11.3%
3.6
114.4
4.5%
27.6%
Key Performanace Ind.
13.6
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-2.2%-81,515Contract Allowance
Total Charges 3,726,331
102.2%
82.7%
17.3%
0.6%
0.0%
17.8%
Current Assets
Fixed Assets
3,807,846
3,149,581
658,265
21,279
0
679,544
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142599
DVA RENAL HEALTHCARE INC DBA DECATUR EASTWOOD DIA
794 EAST WOOD STREET
DECATUR, IL 62521
MACON
BLUE CROSS (GEORGIA)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
13,904,100
Income Statement
280,095
0
14,184,195
760,427
7,725
13,416,044
14,184,196 8.9%
8.2%
3.5
100.6
4.2%
27.5%
Key Performanace Ind.
18.3
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-13.0%-486,354Contract Allowance
Total Charges 3,732,229
113.0%
72.0%
28.0%
0.2%
0.0%
28.2%
Current Assets
Fixed Assets
4,218,583
3,037,659
1,180,924
7,607
0
1,188,531
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 28
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142580
DVA RENAL HEALTHCARE INC DBA EFFINGHAM DIALYSISIS
904 MEDICAL PARK DRIVE, SUITE 1
EFFINGHAM, IL 62401
EFFINGHAM
BLUE CROSS (GEORGIA)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
15,762,226
Income Statement
180,232
1,005,487
16,947,945
625,500
20,353
16,302,092
16,947,945 5.3%
8.2%
5.1
111.0
3.7%
28.6%
Key Performanace Ind.
25.2
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-8.9%-266,112Contract Allowance
Total Charges 2,985,839
108.9%
73.6%
26.4%
0.0%
0.0%
26.4%
Current Assets
Fixed Assets
3,251,951
2,393,926
858,025
1,168
0
859,193
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142581
DVA RENAL HEALTHCARE INC DBA JACKSONVILLE DIALYSIS
1515 W WALNUT
JACKSONVILLE, IL 62650
MORGAN
BLUE CROSS (GEORGIA)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
7,711,512
Income Statement
268,344
1,482,081
9,461,937
145,775
0
9,316,160
9,461,935 2.5%
5.9%
5.6
156.9
5.9%
34.4%
Key Performanace Ind.
52.9
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%-595Contract Allowance
Total Charges 1,922,909
100.0%
88.8%
11.2%
0.7%
0.0%
11.9%
Current Assets
Fixed Assets
1,923,504
1,709,015
214,489
14,396
0
228,885
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 29
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142582
DVA RENAL HEALTHCARE INC DBA LINCOLN DIALYSIS
2100 W 5TH ST
LINCOLN, IL 62656
LOGAN
BLUE CROSS (GEORGIA)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
4,918,037
Income Statement
73,281
646,521
5,637,839
51,074
0
5,586,765
5,637,839 10.2%
6.4%
5.6
168.2
4.9%
36.9%
Key Performanace Ind.
96.3
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-110.0%-876,075Contract Allowance
Total Charges 796,507
210.0%
67.7%
32.3%
1.9%
0.0%
34.2%
Current Assets
Fixed Assets
1,672,582
1,132,121
540,461
32,041
0
572,502
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142583
DVA RENAL HEALTHCARE INC DBA LITCHFIELD DIALYSIS
915 ST FRANCIS WAY
LITCHFIELD, IL 62056
MONTGOMERY
BLUE CROSS (GEORGIA)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
6,148,498
Income Statement
85,872
846,712
7,081,082
357,781
4,156
6,719,146
7,081,083 8.5%
9.1%
8.4
83.4
5.0%
36.6%
Key Performanace Ind.
17.2
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-10.1%-217,307Contract Allowance
Total Charges 2,148,919
110.1%
75.8%
24.2%
0.0%
0.0%
24.3%
Current Assets
Fixed Assets
2,366,226
1,792,539
573,687
597
0
574,284
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 30
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142620
DVA RENAL HEALTHCARE INC DBA RUSHVILLE DIALYSIS
112 SULLIVAN DRIVE
RUSHVILLE, IL 62681
SCHUYLER
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
1,869,569
Income Statement
53,664
0
1,923,233
514,163
0
1,409,071
1,923,234 -1.8%
8.8%
3.8
281.9
5.0%
29.8%
Key Performanace Ind.
3.6
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-0.2%-2,451Contract Allowance
Total Charges 1,026,254
100.2%
102.5%
-2.5%
0.0%
0.0%
-2.5%
Current Assets
Fixed Assets
1,028,705
1,054,306
-25,601
350
0
(25,251)
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142587
DVA RENAL HEALTHCARE INC DBA TAYLORVILLE DIALYSIS
901 W SPRESSER
TAYLORVILLE, IL 62568
CHRISTIAN
BLUE CROSS (GEORGIA)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
3,593,419
Income Statement
324,418
918,646
4,836,483
115,516
8,800
4,712,169
4,836,485 7.2%
9.6%
3.6
75.2
6.2%
36.8%
Key Performanace Ind.
31.1
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-3.5%-61,199Contract Allowance
Total Charges 1,747,728
103.5%
82.0%
18.0%
0.9%
0.0%
18.9%
Current Assets
Fixed Assets
1,808,927
1,483,911
325,016
16,616
0
341,632
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 31
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142585
DVA RENAL HEALTHCARE IND DBA MATTOON DIALYSIS
6051 DEVELOPMENT DRIVE
CHARLESTON, IL 61920
COLES
BLUE CROSS (GEORGIA)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
13,442,125
Income Statement
661,818
1,346,732
15,450,675
554,596
52,776
14,843,303
15,450,675 8.7%
10.5%
3.8
102.0
3.8%
26.4%
Key Performanace Ind.
24.2
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-19.9%-758,136Contract Allowance
Total Charges 3,806,648
119.9%
71.9%
28.1%
0.0%
0.0%
28.2%
Current Assets
Fixed Assets
4,564,784
3,279,914
1,284,870
1,523
0
1,286,393
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142701
EDWARDSVILLE DIALYSIS
235 SOUTH BUCHANAN STREET
EDWARDSVILLE, IL 62025
MADISON
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
3,599,348
Income Statement
131,383
1,870
3,732,601
601,595
16,329
3,114,678
3,732,602 8.4%
12.7%
3.6
56.3
5.8%
30.1%
Key Performanace Ind.
6.0
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-2.8%-48,097Contract Allowance
Total Charges 1,740,425
102.8%
85.8%
14.2%
0.4%
0.0%
14.6%
Current Assets
Fixed Assets
1,788,522
1,534,797
253,725
8,039
0
261,764
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 32
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142507
ELK GROVE DIALYSIS CENTER
901 BEISTERFIELD RD SUITE 400
ELK GROVE VILLAGE, IL 60007
COOK
BLUE CROSS (TEXAS)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
32,223,135
Income Statement
503,494
10,184
32,736,813
-340,698
-3,197,504
-29,198,612
-32,736,814 -10.1%
44.3%
(26.3)
97.7
11.6%
38.2%
Key Performanace Ind.
(94.6)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 7,685,053
100.0%
61.6%
38.4%
0.0%
0.0%
38.4%
Current Assets
Fixed Assets
7,685,053
4,732,792
2,952,261
1
0
2,952,262
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142594
ELK GROVE HOME DIALYSIS CENTER
901 BIESTERFIELD ROAD SUITE 401
ELK GROVE VILLAGE, IL 60007
COOK
BLUE CROSS (TEXAS)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
9,272,252
Income Statement
16,167
0
9,288,419
-57,945
-1,954,268
-7,276,207
-9,288,420 -19.9%
31.7%
(13.9)
119.2
5.3%
27.3%
Key Performanace Ind.
(160.0)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 2,963,855
100.0%
51.2%
48.8%
0.0%
0.0%
48.8%
Current Assets
Fixed Assets
2,963,855
1,516,938
1,446,917
0
0
1,446,917
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 33
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142511
EVANSTON RENAL CENTER
1922 DEMPSTER ST
EVANSTON, IL 60202
COOK
BLUE CROSS (FLORIDA)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
-92,193
Income Statement
1,066,505
0
974,312
476,255
84,101
413,956
974,312 141.3%
13.9%
4.8
158.3
4.7%
32.8%
Key Performanace Ind.
(0.2)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
1.5%66,035Contract Allowance
Total Charges 4,271,389
98.5%
86.3%
13.7%
0.2%
0.0%
13.9%
Current Assets
Fixed Assets
4,205,354
3,630,395
574,959
9,899
0
584,858
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142775
FLOSSMOOR HOME DIALYSIS
19720 GOVERNOR'S HWY
FLOSSMOOR, IL 60422
COOK
DUMMY FOR MEDICAID HHA
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
3,334,397
Income Statement
509,784
0
3,844,181
1,574,738
6,184
2,263,258
3,844,180 85.5%
11.4%
1.8
128.0
2.2%
15.0%
Key Performanace Ind.
2.1
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-2.2%-120,342Contract Allowance
Total Charges 5,424,135
102.2%
42.6%
57.4%
-22.5%
0.0%
34.9%
Current Assets
Fixed Assets
5,544,477
2,360,648
3,183,829
-1,248,432
0
1,935,397
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 34
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142658
FMC ALEDO
409 NW 9TH AVENUE
ALEDO, IL 61231
MERCER
DUMMY FOR MEDICAID HHA
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
131,349
Income Statement
59,888
2,328
193,565
39,000
-121,238
-111,328
-193,566 -169.9%
93.6%
26.2
108.4
3.1%
38.1%
Key Performanace Ind.
3.4
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 732,265
100.0%
74.2%
25.8%
0.0%
0.0%
25.8%
Current Assets
Fixed Assets
732,265
543,126
189,139
0
0
189,139
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142630
FMC DIALYSIS SERVICES OF ALSIP
12250 SOUTH CICERO
ALSIP, IL 60803
COOK
BLUE CROSS (TEXAS)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
6,904,603
Income Statement
247,002
1,875
7,153,480
-318,477
-1,413,350
-5,421,654
-7,153,481 -29.4%
11.6%
(40.1)
54.4
9.7%
39.9%
Key Performanace Ind.
(21.7)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 4,490,690
100.0%
64.6%
35.4%
0.0%
0.0%
35.4%
Current Assets
Fixed Assets
4,490,690
2,899,275
1,591,415
2
0
1,591,417
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 35
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142632
FMC DIALYSIS SERVICES OF WILLOWBROOK
6300 S KINGERY HWY SUITE 408
HINSDALE, IL 60527
DUPAGE
BLUE CROSS (TEXAS)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
10,909,110
Income Statement
555,623
5,634
11,470,367
-184,130
-1,012,605
-10,273,631
-11,470,366 -15.7%
15.2%
(20.8)
91.5
9.9%
35.6%
Key Performanace Ind.
(59.2)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 4,842,775
100.0%
66.8%
33.2%
0.0%
0.0%
33.2%
Current Assets
Fixed Assets
4,842,775
3,234,170
1,608,605
2
0
1,608,607
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142631
FMC DIALYSIS SVS OF CONGRESS PKWY
3410 W VAN BUREN ST
CHICAGO, IL 60624
COOK
BLUE CROSS (TEXAS)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
2,631,687
Income Statement
414,853
27,914
3,074,454
-722,652
-779,715
-1,572,087
-3,074,454 -26.9%
22.0%
(67.5)
111.6
8.2%
34.6%
Key Performanace Ind.
(3.6)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 4,331,540
100.0%
90.2%
9.8%
0.0%
0.0%
9.8%
Current Assets
Fixed Assets
4,331,540
3,908,387
423,153
-1
0
423,152
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 36
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142592
FMC GENESEO
600 N COLLEGE AVE, SUITE 150
GENESEO, IL 61254
HENRY
DUMMY FOR MEDICAID HHA
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
198,290
Income Statement
81,000
3,119
282,409
93,819
-22,397
-353,831
-282,409 -104.1%
60.9%
57.9
125.8
6.0%
40.9%
Key Performanace Ind.
2.1
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 959,804
100.0%
61.6%
38.4%
0.0%
0.0%
38.4%
Current Assets
Fixed Assets
959,804
591,500
368,304
1
0
368,305
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142617
FMC GLENDALE HEIGHTS DIALYSIS
130 E ARMY TRAIL
GLENDALE HEIGHTS, IL 60139
DUPAGE
NOVITAS (TEXAS)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
17,637,702
Income Statement
1,175,669
0
18,813,371
-263,497
-2,289,354
-16,260,519
-18,813,370 -17.9%
20.7%
(23.2)
122.7
10.7%
32.9%
Key Performanace Ind.
(66.9)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 7,048,605
100.0%
58.7%
41.3%
0.0%
0.0%
41.3%
Current Assets
Fixed Assets
7,048,605
4,140,952
2,907,653
1
0
2,907,654
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 37
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142526
FMC MOLINE
400 JOHN DEERE ROAD
MOLINE, IL 61265
ROCK ISLAND
DUMMY FOR MEDICAID HHA
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
1,126,710
Income Statement
525,446
46,623
1,698,779
3,813,886
-1,855,130
-3,657,535
-1,698,779 -88.9%
60.0%
320.8
45.3
6.3%
33.7%
Key Performanace Ind.
0.3
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 7,587,055
100.0%
57.2%
42.8%
0.1%
0.0%
42.9%
Current Assets
Fixed Assets
7,587,055
4,338,761
3,248,294
5,003
0
3,253,297
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142520
FMC OF WESTCHESTER
2400 WOLF ROAD SUITE 101A
WESTCHESTER, IL 60154
COOK
BLUE CROSS (TEXAS)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
17,451,323
Income Statement
520,001
12,325
17,983,649
-247,146
-1,381,885
-16,354,619
-17,983,650 -13.5%
19.6%
(30.7)
148.0
10.8%
37.9%
Key Performanace Ind.
(70.6)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 5,142,591
100.0%
57.1%
42.9%
0.0%
0.0%
42.9%
Current Assets
Fixed Assets
5,142,591
2,936,858
2,205,733
0
0
2,205,733
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 38
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142565
FMC SPOON RIVER
340 S AVENUE B
CANTON, IL 61520
FULTON
CGS (KENTUCKY)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
6,504,679
Income Statement
677,632
0
7,182,311
-137,150
-168,930
-6,876,232
-7,182,312 -1.8%
16.4%
(35.4)
34.3
7.0%
34.8%
Key Performanace Ind.
(47.4)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 1,539,646
100.0%
91.8%
8.2%
0.0%
0.0%
8.2%
Current Assets
Fixed Assets
1,539,646
1,412,786
126,860
-1
0
126,859
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142568
FOX VALLEY DIALYSIS
1300 WATERFORD DRIVE
AURORA, IL 60504
DUPAGE
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
4,639,205
Income Statement
97,795
31,064
4,768,064
383,519
0
4,384,545
4,768,064 38.0%
12.7%
12.4
331.6
5.5%
30.3%
Key Performanace Ind.
12.1
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 8,697,425
100.0%
80.9%
19.1%
0.0%
0.0%
19.1%
Current Assets
Fixed Assets
8,697,425
7,036,317
1,661,108
4,076
0
1,665,184
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 39
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142782
FRESENIUS HIGHLAND PARK DIALYSIS
1657 OLD SKOKIE ROAD
HIGHLAND PARK, IL 60035
LAKE
DUMMY FOR MEDICAID HHA
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
-7,289,051
Income Statement
1,813,545
7,915,590
2,440,084
-69,482
-1,785,413
-585,187
-2,440,082 -60.5%
30.6%
(7.6)
277.3
8.9%
32.3%
Key Performanace Ind.
104.9
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 3,698,196
100.0%
90.4%
9.6%
0.0%
0.0%
9.6%
Current Assets
Fixed Assets
3,698,196
3,344,059
354,137
-1
0
354,136
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142823
FRESENIUS KIDNEY CARE EVERGREEN PARK
8901 S KEDZIE
EVERGREEN PARK, IL 60805
COOK
NGS (IL)
12/31/2017 101 Days *Settled
For Profit
End Stage Renal Disease
Balance Sheet
272,232
Income Statement
477,295
0
749,527
-1,255,941
-108,119
614,533
-749,527 -49.8%
39.0%
(210.0)
124.9
6.0%
31.1%
Key Performanace Ind.
(0.2)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 297,620
100.0%
202.9%
-102.9%
0.0%
0.0%
-102.9%
Current Assets
Fixed Assets
297,620
603,961
-306,341
1
0
(306,340)
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 40
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142669
FRESENIUS KIDNEY CARE LAKE BLUFF
101 WAUKEGAN RD SUITE 700
LAKE BLUFF, IL 60044
LAKE
NOVITAS (TEXAS)
12/31/2017 214 Days Settled
For Profit
End Stage Renal Disease
5/31/2017 151 Days Settled
Balance Sheet
9,577,529
Income Statement
142,377
9,183
9,729,089
-255,274
-1,706,950
-7,766,866
-9,729,090 -6.3%
8.9%
(82.0)
237.5
22.5%
47.8%
Key Performanace Ind.
(37.5)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 1,689,311
100.0%
67.3%
32.7%
-3.9%
0.0%
28.8%
Current Assets
Fixed Assets
1,689,311
1,136,138
553,173
-65,992
0
487,181
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142669
FRESENIUS KIDNEY CARE LAKE BLUFF
101 WAUKEGAN RD SUITE 700
LAKE BLUFF, IL 60044
LAKE
NOVITAS (TEXAS)
12/31/2017 214 Days Settled
For Profit
End Stage Renal Disease
5/31/2017 151 Days Settled
Balance Sheet
3,337,784
Income Statement
121,387
7,492
3,466,663
-283,891
-77,109
-3,105,661
-3,466,661 -34.3%
9.4%
(67.4)
216.9
16.6%
35.3%
Key Performanace Ind.
(11.8)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 2,601,667
100.0%
59.1%
40.9%
0.0%
0.0%
40.9%
Current Assets
Fixed Assets
2,601,667
1,537,881
1,063,786
0
0
1,063,786
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 41
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142574
FRESENIUS MEDICAL CARE
410 R B GARRETT AVENUE
PEORIA, IL 61605
PEORIA
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
16,080,861
Income Statement
689,176
13,637
16,783,674
-538,530
-192,227
-16,052,919
-16,783,676 -0.6%
30.2%
(49.8)
119.2
9.1%
34.9%
Key Performanace Ind.
(29.9)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 4,041,154
100.0%
97.8%
2.2%
0.0%
0.0%
2.2%
Current Assets
Fixed Assets
4,041,154
3,950,388
90,766
0
0
90,766
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142578
FRESENIUS MEDICAL CARE - KEWANEE
230 W SOUTH STREET
KEWANEE, IL 61443
HENRY
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
64,429
Income Statement
54,014
12,083
130,526
-158,088
-224,865
252,424
-130,529 116.3%
19.4%
(44.3)
100.0
7.4%
37.2%
Key Performanace Ind.
(0.4)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 1,595,600
100.0%
81.6%
18.4%
0.0%
0.0%
18.4%
Current Assets
Fixed Assets
1,595,600
1,302,146
293,454
2
0
293,456
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 42
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142689
FRESENIUS MEDICAL CARE - MOKENA
8910 W 192ND STREET, SUITE A & B
MOKENA, IL 60448
WILL
NGS (IL)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
3,410,561
Income Statement
284,620
7,492
3,702,673
-109,899
-560,344
-3,032,431
-3,702,674 -26.5%
10.6%
(20.0)
98.0
10.9%
38.9%
Key Performanace Ind.
(31.0)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 2,812,856
100.0%
71.4%
28.6%
0.0%
0.0%
28.6%
Current Assets
Fixed Assets
2,812,856
2,008,347
804,509
1
0
804,510
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142678
FRESENIUS MEDICAL CARE - NAPERVILLE NORTH
516 WEST 5TH AVENUE
NAPERVILLE, IL 60563
DUPAGE
BLUE CROSS (TEXAS)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
13,134,967
Income Statement
1,069,926
6,000
14,210,893
-160,596
-1,534,874
-12,515,423
-14,210,893 -9.7%
11.8%
(21.5)
117.2
8.9%
36.9%
Key Performanace Ind.
(81.8)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 3,938,127
100.0%
69.2%
30.8%
0.0%
0.0%
30.8%
Current Assets
Fixed Assets
3,938,127
2,725,589
1,212,538
0
0
1,212,538
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 43
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142656
FRESENIUS MEDICAL CARE - OTTAWA HOME DIALYSIS
1601 MERCURY CIRCLE DRIVE, SUITE 3A
OTTAWA, IL 61350
LA SALLE
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
3,958,930
Income Statement
2,674
0
3,961,604
-52,426
-559,827
-3,349,351
-3,961,604 -14.6%
271.2%
(41.6)
88.7
5.2%
35.1%
Key Performanace Ind.
(75.5)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 947,975
100.0%
48.6%
51.4%
0.0%
0.0%
51.4%
Current Assets
Fixed Assets
947,975
460,421
487,554
-1
0
487,553
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142809
FRESENIUS MEDICAL CARE ABERDEEN
215 SOUTH ABERDEEN STREET
CHICAGO, IL 60607
COOK
NGS (IL)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
942,656
Income Statement
1,327,577
0
2,270,233
1,627,295
-2,220,160
-1,677,368
-2,270,233 -129.7%
25.0%
353.5
154.4
6.5%
26.9%
Key Performanace Ind.
0.6
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 3,855,900
100.0%
43.6%
56.4%
0.0%
0.0%
56.4%
Current Assets
Fixed Assets
3,855,900
1,680,396
2,175,504
1
0
2,175,505
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 44
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142729
FRESENIUS MEDICAL CARE BATAVIA
2580 WEST FABYAN PARKWAY
BATAVIA, IL 60510
KANE
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
7,170,733
Income Statement
483,243
0
7,653,976
-1,119,461
-2,280,709
-4,253,807
-7,653,977 -51.9%
23.7%
(175.3)
64.9
8.0%
35.7%
Key Performanace Ind.
(6.4)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 4,537,145
100.0%
51.4%
48.6%
0.0%
0.0%
48.6%
Current Assets
Fixed Assets
4,537,145
2,331,084
2,206,061
-1
0
2,206,060
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142533
FRESENIUS MEDICAL CARE BERWYN
2601 HARLEM AVENUE
BERWYN, IL 60402
COOK
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
-74,507,465
Income Statement
722,762
0
-73,784,703
-624,624
-3,332,271
77,741,598
73,784,703 4.3%
15.6%
(43.8)
104.4
9.1%
38.3%
Key Performanace Ind.
119.3
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 8,543,385
100.0%
60.9%
39.1%
0.0%
0.0%
39.1%
Current Assets
Fixed Assets
8,543,385
5,201,507
3,341,878
0
0
3,341,878
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 45
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142539
FRESENIUS MEDICAL CARE BLUE ISLAND
12200 WESTERN AVENUE, SUITE 120
BLUE ISLAND, IL 60406
COOK
BLUE CROSS (TEXAS)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
14,537,955
Income Statement
484,470
15,786
15,038,211
-714,177
-2,511,331
-11,812,703
-15,038,211 -19.0%
25.6%
(55.2)
87.9
9.1%
37.8%
Key Performanace Ind.
(20.4)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 6,967,813
100.0%
67.8%
32.2%
0.0%
0.0%
32.2%
Current Assets
Fixed Assets
6,967,813
4,725,509
2,242,304
0
0
2,242,304
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142524
FRESENIUS MEDICAL CARE BRIDGEPORT
825 WEST 35TH STREET
CHICAGO, IL 60609
COOK
NOVITAS (TEXAS)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
1,610,294
Income Statement
784,101
0
2,394,395
7,812,273
-2,080,223
-8,126,444
-2,394,394 -33.8%
25.7%
619.6
141.8
9.5%
38.1%
Key Performanace Ind.
0.2
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 7,346,182
100.0%
62.6%
37.4%
0.0%
0.0%
37.4%
Current Assets
Fixed Assets
7,346,182
4,601,908
2,744,274
2
0
2,744,276
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 46
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142641
FRESENIUS MEDICAL CARE BURBANK
4811 WEST 77TH STREET
BURBANK, IL 60459
COOK
NOVITAS (TEXAS)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
1,343,523
Income Statement
291,875
14,500
1,649,898
11,203,268
-2,813,366
-10,039,799
-1,649,897 -33.9%
14.4%
1,062.0
54.8
11.2%
40.9%
Key Performanace Ind.
0.1
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 7,250,154
100.0%
53.1%
46.9%
0.0%
0.0%
46.9%
Current Assets
Fixed Assets
7,250,154
3,850,601
3,399,553
0
0
3,399,553
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142744
FRESENIUS MEDICAL CARE CHATHAM DIALYSIS
8710 S HOLLAND ROAD
CHICAGO, IL 60620
COOK
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
3,837,030
Income Statement
620,423
7,315
4,464,768
-1,141,858
-1,402,512
-1,920,397
-4,464,767 -28.7%
29.1%
(129.0)
57.1
7.6%
36.0%
Key Performanace Ind.
(3.4)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 3,781,433
100.0%
85.4%
14.6%
0.0%
0.0%
14.6%
Current Assets
Fixed Assets
3,781,433
3,230,654
550,779
2
0
550,781
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 47
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142506
FRESENIUS MEDICAL CARE CHICAGO
1806 W HUBBARD ST
CHICAGO, IL 60622
COOK
NOVITAS (TEXAS)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
1,142,242
Income Statement
414,395
0
1,556,637
-892,879
-1,073,437
409,678
-1,556,638 -43.5%
82.3%
(124.1)
303.3
7.7%
33.0%
Key Performanace Ind.
(1.3)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 2,448,278
100.0%
107.3%
-7.3%
0.0%
0.0%
-7.3%
Current Assets
Fixed Assets
2,448,278
2,626,643
-178,365
-1
0
(178,366)
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142754
FRESENIUS MEDICAL CARE CICERO
3000 S CICERO AVE
CICERO, IL 60804
COOK
DUMMY FOR MEDICAID HHA
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
5,075,921
Income Statement
711,063
26,074
5,813,058
-1,373,377
-1,911,814
-2,527,865
-5,813,056 -74.8%
28.1%
(229.2)
53.5
7.8%
33.2%
Key Performanace Ind.
(3.7)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 4,077,077
100.0%
53.6%
46.4%
0.0%
0.0%
46.4%
Current Assets
Fixed Assets
4,077,077
2,186,975
1,890,102
2
0
1,890,104
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 48
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142774
FRESENIUS MEDICAL CARE DES PLAINES
1625 OAKTON PLACE
DES PLAINES, IL 60018
COOK
DUMMY FOR MEDICAID HHA
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
1,818,384
Income Statement
764,901
2,194
2,585,479
-609,215
-929,328
-1,046,935
-2,585,478 -49.2%
20.0%
(136.5)
88.4
8.1%
35.9%
Key Performanace Ind.
(3.0)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 2,143,989
100.0%
76.0%
24.0%
0.0%
0.0%
24.0%
Current Assets
Fixed Assets
2,143,989
1,629,125
514,864
-1
0
514,863
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142595
FRESENIUS MEDICAL CARE DUQUOIN
825 SUNSET AVE
DU QUOIN, IL 62832
PERRY
BLUE CROSS (TEXAS)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
-263,601
Income Statement
784,962
0
521,361
-146,778
-223,825
-150,759
-521,362 176.3%
19.3%
(29.7)
103.4
7.7%
27.5%
Key Performanace Ind.
1.8
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 1,537,871
100.0%
117.3%
-17.3%
0.0%
0.0%
-17.3%
Current Assets
Fixed Assets
1,537,871
1,803,634
-265,763
-1
0
(265,764)
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 49
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142726
FRESENIUS MEDICAL CARE ELGIN, LLC
2130 POINT BLVD, STE 800
ELGIN, IL 60123
KANE
NGS (IL)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
10,326,777
Income Statement
960,565
49,452
11,336,794
-1,675,895
-3,753,623
-5,907,276
-11,336,794 -58.6%
18.2%
(169.7)
56.9
10.0%
36.0%
Key Performanace Ind.
(6.2)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 7,063,041
100.0%
51.0%
49.0%
0.0%
0.0%
49.0%
Current Assets
Fixed Assets
7,063,041
3,603,743
3,459,298
1
0
3,459,299
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142612
FRESENIUS MEDICAL CARE ELMHURST
133 EAST BRUSH HILL ROAD
ELMHURST, IL 60126
DUPAGE
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
33,552,278
Income Statement
798,827
3,564,793
37,915,898
-317,426
-3,240,210
-34,358,261
-37,915,897 -7.9%
29.4%
(30.5)
86.2
9.0%
36.0%
Key Performanace Ind.
(105.7)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 6,525,601
100.0%
58.2%
41.8%
0.0%
0.0%
41.8%
Current Assets
Fixed Assets
6,525,601
3,795,231
2,730,370
-1
0
2,730,369
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 50
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142579
FRESENIUS MEDICAL CARE GALESBURG
765 N KELLOGG ST
GALESBURG, IL 61401
KNOX
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
-199,969
Income Statement
78,290
7,000,353
6,878,674
-307,940
-197,031
-6,373,704
-6,878,675 -14.9%
45.9%
(41.5)
51.6
10.1%
34.1%
Key Performanace Ind.
0.6
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 3,659,992
100.0%
74.1%
25.9%
0.0%
0.0%
25.9%
Current Assets
Fixed Assets
3,659,992
2,710,341
949,651
-1
0
949,650
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142555
FRESENIUS MEDICAL CARE GARFIELD
5401 S WENTWORTH
CHICAGO, IL 60659
COOK
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
-63,524,092
Income Statement
323,321
19,817
-63,180,954
-537,640
-801,568
64,520,161
63,180,953 0.4%
14.3%
(57.5)
102.4
9.5%
38.2%
Key Performanace Ind.
118.2
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 3,648,178
100.0%
93.6%
6.4%
0.0%
0.0%
6.4%
Current Assets
Fixed Assets
3,648,178
3,413,572
234,606
-1
0
234,605
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 51
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142549
FRESENIUS MEDICAL CARE GURNEE
50 TOWER COURT
GURNEE, IL 60031
LAKE
NOVITAS (TEXAS)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
1,167,217
Income Statement
478,869
5,468
1,651,554
5,420,533
-1,707,768
-5,364,320
-1,651,555 -53.1%
52.9%
643.0
429.0
8.0%
37.2%
Key Performanace Ind.
0.2
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 5,924,361
100.0%
51.9%
48.1%
0.0%
0.0%
48.1%
Current Assets
Fixed Assets
5,924,361
3,077,099
2,847,262
1
0
2,847,263
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142607
FRESENIUS MEDICAL CARE HAZEL CREST
17524 CARRIAGE WAY
HAZEL CREST, IL 60429
COOK
NOVITAS (TEXAS)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
921,376
Income Statement
448,149
0
1,369,525
2,878,716
-1,025,195
-3,223,044
-1,369,523 -44.2%
29.0%
395.5
71.1
8.9%
38.5%
Key Performanace Ind.
0.3
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 4,081,144
100.0%
65.1%
34.9%
0.0%
0.0%
34.9%
Current Assets
Fixed Assets
4,081,144
2,656,992
1,424,152
-2
0
1,424,150
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 52
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142547
FRESENIUS MEDICAL CARE HOFFMAN ESTATES
3150 W HIGGINS RD, SUITE 190
HOFFMAN ESTATES, IL 60195
COOK
NOVITAS (TEXAS)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
1,144,564
Income Statement
341,941
5,438
1,491,943
12,868,131
-3,091,126
-11,268,947
-1,491,942 -30.5%
14.8%
1,551.0
117.1
11.4%
40.6%
Key Performanace Ind.
0.1
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 6,465,047
100.0%
46.8%
53.2%
0.0%
0.0%
53.2%
Current Assets
Fixed Assets
6,465,047
3,028,372
3,436,675
0
0
3,436,675
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142739
FRESENIUS MEDICAL CARE JOLIET
721 EAST JACKSON STREET
JOLIET, IL 60432
WILL
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
2,652,325
Income Statement
636,255
0
3,288,580
-1,678,765
-292,866
-1,316,950
-3,288,581 -58.7%
26.6%
(265.4)
67.1
8.1%
34.4%
Key Performanace Ind.
(1.6)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 3,081,590
100.0%
74.9%
25.1%
0.0%
0.0%
25.1%
Current Assets
Fixed Assets
3,081,590
2,309,019
772,571
0
0
772,571
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 53
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142819
FRESENIUS MEDICAL CARE KOKE MILL, LLC
2550 S KOKE MILL ROAD
SPRINGFIELD, IL 62711
SANGAMON
DUMMY FOR MEDICAID HHA
12/31/2017 131 Days *Settled
For Profit
End Stage Renal Disease
Balance Sheet
758,044
Income Statement
1,282,019
0
2,040,063
-103,705
-37,422
-1,898,934
-2,040,061 0.2%
8.9%
(50.8)
99.4
5.8%
28.8%
Key Performanace Ind.
(7.3)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 263,028
100.0%
101.7%
-1.7%
0.0%
0.0%
-1.7%
Current Assets
Fixed Assets
263,028
267,517
-4,489
1
0
(4,488)
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142679
FRESENIUS MEDICAL CARE LAKEVIEW
4008 N BROADWAY
CHICAGO, IL 60613
COOK
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
365,155
Income Statement
587,731
0
952,886
2,040,923
-1,306,561
-1,687,247
-952,885 -50.4%
26.4%
394.4
68.4
7.1%
34.1%
Key Performanace Ind.
0.2
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 2,739,723
100.0%
68.9%
31.1%
0.0%
0.0%
31.1%
Current Assets
Fixed Assets
2,739,723
1,888,944
850,779
-1
0
850,778
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 54
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142798
FRESENIUS MEDICAL CARE LEMONT
16177 W 127TH STREET
LEMONT, IL 60439
COOK
NGS (IL)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
-809,066
Income Statement
1,324,339
732
516,005
-137,703
-204,340
-173,960
-516,003 298.0%
32.2%
(36.4)
62.2
4.3%
26.8%
Key Performanace Ind.
5.9
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 863,751
100.0%
160.0%
-60.0%
0.0%
0.0%
-60.0%
Current Assets
Fixed Assets
863,751
1,382,144
-518,393
2
0
(518,391)
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142766
FRESENIUS MEDICAL CARE LOGAN SQUARE
2721 N SPAULDING
CHICAGO, IL 60647
COOK
DUMMY FOR MEDICAID HHA
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
4,591,359
Income Statement
705,771
3,657
5,300,787
-1,560,443
-2,234,625
-1,505,719
-5,300,787 -74.4%
24.1%
(268.1)
54.2
7.2%
35.0%
Key Performanace Ind.
(2.9)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 3,245,069
100.0%
65.5%
34.5%
0.0%
0.0%
34.5%
Current Assets
Fixed Assets
3,245,069
2,124,248
1,120,821
1
0
1,120,822
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 55
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142722
FRESENIUS MEDICAL CARE LOMBARD
1940 SPRINGER DRIVE
LOMBARD, IL 60148
DUPAGE
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
7,828,706
Income Statement
328,406
26,774
8,183,886
-1,072,178
-1,662,023
-5,449,687
-8,183,888 -62.3%
14.1%
(135.2)
53.4
8.9%
31.4%
Key Performanace Ind.
(7.3)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 6,291,384
100.0%
46.0%
54.0%
0.0%
0.0%
54.0%
Current Assets
Fixed Assets
6,291,384
2,895,597
3,395,787
-1
0
3,395,786
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142790
FRESENIUS MEDICAL CARE MAPLE CITY
1225 NORTH MAIN STREET
MONMOUTH, IL 61462
WARREN
NGS (IL)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
-1,087,874
Income Statement
293,565
0
-794,309
-13,526
-223,200
1,031,036
794,310 -15.1%
108.0%
(4.5)
59.7
2.8%
25.2%
Key Performanace Ind.
80.4
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 949,192
100.0%
116.4%
-16.4%
0.0%
0.0%
-16.4%
Current Assets
Fixed Assets
949,192
1,105,064
-155,872
0
0
(155,872)
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 56
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142566
FRESENIUS MEDICAL CARE MARQUETTE PARK
6535 S WESTERN AVE
CHICAGO, IL 60636
COOK
NOVITAS (TEXAS)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
717,774
Income Statement
317,022
0
1,034,796
3,750,789
-1,999,391
-2,786,194
-1,034,796 -55.1%
25.1%
466.9
97.7
8.4%
38.6%
Key Performanace Ind.
0.2
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 4,466,582
100.0%
65.7%
34.3%
0.0%
0.0%
34.3%
Current Assets
Fixed Assets
4,466,582
2,932,434
1,534,148
2
0
1,534,150
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142563
FRESENIUS MEDICAL CARE MCLEAN COUNTY
1505 EASTLAND DR
BLOOMINGTON, IL 61701
MCLEAN
CGS (KENTUCKY)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
633,357
Income Statement
391,353
7,008
1,031,718
5,921,534
-1,754,938
-5,198,315
-1,031,719 -73.3%
13.5%
945.2
63.0
10.5%
41.3%
Key Performanace Ind.
0.1
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 6,098,060
100.0%
37.5%
62.5%
0.0%
0.0%
62.5%
Current Assets
Fixed Assets
6,098,060
2,286,761
3,811,299
-1
0
3,811,298
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 57
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142554
FRESENIUS MEDICAL CARE MELROSE PARK
1111 SUPERIOR ST SUITE 204
MELROSE PARK, IL 60160
COOK
NOVITAS (TEXAS)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
763,629
Income Statement
99,369
3,034
866,032
8,666,059
-2,959,561
-6,572,530
-866,032 -41.9%
58.6%
1,434.2
99.2
9.0%
39.8%
Key Performanace Ind.
0.1
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 4,957,616
100.0%
44.5%
55.5%
0.0%
0.0%
55.5%
Current Assets
Fixed Assets
4,957,616
2,205,484
2,752,132
0
0
2,752,132
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142713
FRESENIUS MEDICAL CARE MIDWAY DIALYSIS
6201 W 63RD ST
CHICAGO, IL 60638
COOK
DUMMY FOR MEDICAID HHA
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
715,144
Income Statement
129,050
9,831
854,025
6,927,388
-1,568,026
-6,213,384
-854,022 -26.5%
51.7%
1,174.0
120.6
7.5%
38.5%
Key Performanace Ind.
0.1
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 3,798,166
100.0%
56.7%
43.3%
0.0%
0.0%
43.3%
Current Assets
Fixed Assets
3,798,166
2,153,694
1,644,472
-2
0
1,644,470
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 58
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142731
FRESENIUS MEDICAL CARE MUNDELEIN
1402 TOWNLINE ROAD
MUNDELEIN, IL 60060
LAKE
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
4,531,105
Income Statement
492,127
0
5,023,232
-142,114
-1,416,453
-3,464,665
-5,023,232 -33.5%
19.7%
(25.8)
135.8
9.3%
38.2%
Key Performanace Ind.
(31.9)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 3,174,240
100.0%
63.4%
36.6%
0.0%
0.0%
36.6%
Current Assets
Fixed Assets
3,174,240
2,013,277
1,160,963
0
0
1,160,963
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142765
FRESENIUS MEDICAL CARE NAPERBROOK
2451 S WASHINGTON ST
NAPERVILLE, IL 60565
DUPAGE
DUMMY FOR MEDICAID HHA
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
8,374,464
Income Statement
1,030,970
46,901
9,452,335
-1,461,256
-3,006,790
-4,984,289
-9,452,335 -70.0%
30.6%
(144.9)
(25.9)
9.3%
33.3%
Key Performanace Ind.
(5.7)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 7,170,032
100.0%
51.3%
48.7%
0.0%
0.0%
48.7%
Current Assets
Fixed Assets
7,170,032
3,679,760
3,490,272
-1
0
3,490,271
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 59
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142815
FRESENIUS MEDICAL CARE NEW CITY
4616 S BISHOP
CHICAGO, IL 60609
COOK
DUMMY FOR MEDICAID HHA
12/31/2017 210 Days *Settled
For Profit
End Stage Renal Disease
Balance Sheet
386,826
Income Statement
346,089
0
732,915
-1,652,119
318,593
600,611
-732,915 -21.7%
60.6%
(596.3)
312.1
2.6%
24.5%
Key Performanace Ind.
(0.2)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 451,423
100.0%
128.9%
-28.9%
0.0%
0.0%
-28.9%
Current Assets
Fixed Assets
451,423
581,876
-130,453
0
0
(130,453)
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142559
FRESENIUS MEDICAL CARE NILES
9371 NORTH MILWAUKEE AVE
NILES, IL 60714
COOK
NOVITAS (TEXAS)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
1,147,036
Income Statement
264,411
14,017
1,425,464
12,162,238
-3,320,317
-10,267,386
-1,425,465 -40.9%
22.9%
1,136.6
46.0
9.7%
35.4%
Key Performanace Ind.
0.1
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 8,109,090
100.0%
48.2%
51.8%
0.0%
0.0%
51.8%
Current Assets
Fixed Assets
8,109,090
3,905,856
4,203,234
0
0
4,203,234
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 60
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142778
FRESENIUS MEDICAL CARE NORMAL
1531 E COLLEGE AVE, SUITE 1
NORMAL, IL 61761
MCLEAN
DUMMY FOR MEDICAID HHA
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
600,502
Income Statement
1,065,145
0
1,665,647
-931,017
-811,863
77,234
-1,665,646 469.6%
16.5%
(212.9)
193.0
6.2%
34.7%
Key Performanace Ind.
(0.6)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 1,959,125
100.0%
81.5%
18.5%
0.0%
0.0%
18.5%
Current Assets
Fixed Assets
1,959,125
1,596,474
362,651
2
0
362,653
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142521
FRESENIUS MEDICAL CARE NORRIDGE
4701 NORTH CUMBERLAND
NORRIDGE, IL 60706
ADAMS
MUTUAL LEGACY
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
742,400
Income Statement
127,725
8,257
878,382
7,239,006
-2,421,355
-5,696,035
-878,384 -52.1%
16.6%
1,189.9
95.3
10.8%
40.3%
Key Performanace Ind.
0.1
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 5,189,288
100.0%
42.8%
57.2%
0.0%
0.0%
57.2%
Current Assets
Fixed Assets
5,189,288
2,220,585
2,968,703
-1
0
2,968,702
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 61
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142602
FRESENIUS MEDICAL CARE NORTH AVENUE
719 WEST NORTH AVENUE
MELROSE PARK, IL 60160
COOK
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
17,990,948
Income Statement
560,370
14,500
18,565,818
-434,309
-1,387,154
-16,744,356
-18,565,819 -10.8%
29.1%
(37.3)
82.8
8.6%
36.1%
Key Performanace Ind.
(41.4)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 6,054,720
100.0%
70.1%
29.9%
0.0%
0.0%
29.9%
Current Assets
Fixed Assets
6,054,720
4,246,200
1,808,520
0
0
1,808,520
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142501
FRESENIUS MEDICAL CARE NORTH KILPATRICK
4800 NORTH KILPATRICK
CHICAGO, IL 60630
COOK
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
1,392,846
Income Statement
907,285
11,099
2,311,230
18,701,313
-5,642,110
-15,370,433
-2,311,230 -29.6%
20.7%
1,463.3
91.8
10.9%
39.4%
Key Performanace Ind.
0.1
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 9,208,833
100.0%
50.7%
49.3%
0.0%
0.0%
49.3%
Current Assets
Fixed Assets
9,208,833
4,664,629
4,544,204
-1
0
4,544,203
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 62
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142531
FRESENIUS MEDICAL CARE NORTHCENTER
2620 W. ADDISON
CHICAGO, IL 60618
COOK
NOVITAS (TEXAS)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
750,104
Income Statement
209,636
0
959,740
10,726,403
-3,582,339
-8,103,804
-959,740 -20.9%
37.6%
1,847.5
121.0
9.5%
35.1%
Key Performanace Ind.
0.1
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 3,814,926
100.0%
55.5%
44.5%
0.0%
0.0%
44.5%
Current Assets
Fixed Assets
3,814,926
2,119,125
1,695,801
-1
0
1,695,800
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142771
FRESENIUS MEDICAL CARE NORTHFIELD DIALYSIS
480 CENTRAL AVE
NORTHFIELD, IL 60093
COOK
DUMMY FOR MEDICAID HHA
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
-4,070,186
Income Statement
891,025
0
-3,179,161
-9,784
-325,287
3,514,235
3,179,164 -16.6%
24.6%
(3.8)
170.0
2.4%
25.8%
Key Performanace Ind.
416.0
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 365,195
100.0%
259.7%
-159.7%
0.0%
0.0%
-159.7%
Current Assets
Fixed Assets
365,195
948,375
-583,180
1
0
(583,179)
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 63
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142764
FRESENIUS MEDICAL CARE OAK FOREST
5340A W 159TH ST
OAK FOREST, IL 60452
COOK
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
7,024,379
Income Statement
755,304
0
7,779,683
-1,777,013
-2,600,955
-3,401,716
-7,779,684 -57.5%
33.0%
(228.1)
55.7
7.2%
31.8%
Key Performanace Ind.
(4.0)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 4,800,158
100.0%
59.2%
40.8%
0.0%
0.0%
40.8%
Current Assets
Fixed Assets
4,800,158
2,843,479
1,956,679
0
0
1,956,679
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142504
FRESENIUS MEDICAL CARE OAK PARK DIALYSIS
733 WEST MADISON
OAK PARK, IL 60302
COOK
NOVITAS (TEXAS)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
670,203
Income Statement
878,960
11,797
1,560,960
1,745,574
-793,915
-2,512,619
-1,560,960 -62.5%
22.4%
255.9
50.6
9.8%
39.7%
Key Performanace Ind.
0.4
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 4,060,438
100.0%
61.3%
38.7%
0.0%
0.0%
38.7%
Current Assets
Fixed Assets
4,060,438
2,490,129
1,570,309
-3
0
1,570,306
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 64
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142673
FRESENIUS MEDICAL CARE OF ANTIOCH
311 DEPOT
ANTIOCH, IL 60002
LAKE
DUMMY FOR MEDICAID HHA
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
328,279
Income Statement
427,275
7,492
763,046
1,379,088
-544,476
-1,597,657
-763,045 -33.5%
9.9%
314.5
90.4
8.6%
38.8%
Key Performanace Ind.
0.2
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 2,135,149
100.0%
75.0%
25.0%
0.0%
0.0%
25.0%
Current Assets
Fixed Assets
2,135,149
1,600,682
534,467
-1
0
534,466
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142710
FRESENIUS MEDICAL CARE OF DEERFIELD
405 LAKE COOK ROAD, SUITE A13
DEERFIELD, IL 60015
LAKE
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
2,731,929
Income Statement
91,669
0
2,823,598
-64,151
-908,889
-1,850,558
-2,823,598 -21.5%
68.8%
(13.9)
73.1
7.1%
32.8%
Key Performanace Ind.
(42.6)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 2,079,146
100.0%
80.8%
19.2%
0.0%
0.0%
19.2%
Current Assets
Fixed Assets
2,079,146
1,680,888
398,258
1
0
398,259
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 65
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142509
FRESENIUS MEDICAL CARE OF DUPAGE WEST
450 EAST ROOSEVELT ROAD, SUITE 101
WEST CHICAGO, IL 60185
DUPAGE
BLUE CROSS (TEXAS)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
30,418,161
Income Statement
144,594
8,942
30,571,697
-286,082
-2,227,390
-28,058,225
-30,571,697 -11.9%
17.1%
(33.1)
111.3
9.4%
37.3%
Key Performanace Ind.
(106.3)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 6,479,379
100.0%
48.7%
51.3%
0.0%
0.0%
51.3%
Current Assets
Fixed Assets
6,479,379
3,153,158
3,326,221
-1
0
3,326,220
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142705
FRESENIUS MEDICAL CARE OF ILLINOIS LLC
20 HOSPITAL DRIVE
METROPOLIS, IL 62960
MASSAC
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
2,283,785
Income Statement
143,438
0
2,427,223
-51,348
-45,387
-2,330,488
-2,427,223 -89.7%
14.6%
(17.6)
51.6
5.3%
32.2%
Key Performanace Ind.
(44.5)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 3,152,305
100.0%
33.7%
66.3%
0.0%
0.0%
66.3%
Current Assets
Fixed Assets
3,152,305
1,062,263
2,090,042
2
0
2,090,044
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 66
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142606
FRESENIUS MEDICAL CARE OF ILLINOIS, LLC
501 W LAKE STREET STE 201
ELMHURST, IL 60126
DUPAGE
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
3,609,410
Income Statement
48,736
1,801,110
5,459,256
-29,902
-256,675
-5,172,677
-5,459,254 3.1%
22.9%
(14.1)
43.1
4.6%
28.1%
Key Performanace Ind.
(120.7)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 615,181
100.0%
126.2%
-26.2%
0.0%
0.0%
-26.2%
Current Assets
Fixed Assets
615,181
776,354
-161,173
0
0
(161,173)
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142681
FRESENIUS MEDICAL CARE OF ILLINOIS, LLC
1340 SOUTH DAMEN AVE
CHICAGO, IL 60608
COOK
BLUE CROSS (TEXAS)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
3,130,848
Income Statement
115,664
8,700
3,255,212
-361,161
-1,845,436
-1,048,615
-3,255,212 -82.6%
14.2%
(57.7)
190.8
10.3%
34.3%
Key Performanace Ind.
(8.7)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 3,151,397
100.0%
72.5%
27.5%
0.0%
0.0%
27.5%
Current Assets
Fixed Assets
3,151,397
2,285,586
865,811
0
0
865,811
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 67
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142789
FRESENIUS MEDICAL CARE OF ILLINOIS, LLC
624 VORIS-JOST DRIVE
WATERLOO, IL 62298
MONROE
DUMMY FOR MEDICAID HHA
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
-1,006,653
Income Statement
1,133,189
0
126,536
-18,030
-416,722
308,215
-126,537 113.7%
28.1%
(4.6)
26.3
4.4%
22.5%
Key Performanace Ind.
55.8
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 1,795,303
100.0%
80.5%
19.5%
0.0%
0.0%
19.5%
Current Assets
Fixed Assets
1,795,303
1,444,934
350,369
-1
0
350,368
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142672
FRESENIUS MEDICAL CARE OF MCHENRY
4312 W ELM ST
MCHENRY, IL 60050
MCHENRY
NOVITAS (TEXAS)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
483,889
Income Statement
388,599
7,733
880,221
771,638
-801,735
-850,126
-880,223 -65.4%
11.8%
160.6
134.1
9.5%
40.1%
Key Performanace Ind.
0.6
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 2,309,331
100.0%
75.9%
24.1%
0.0%
0.0%
24.1%
Current Assets
Fixed Assets
2,309,331
1,753,198
556,133
1
0
556,134
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 68
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142707
FRESENIUS MEDICAL CARE OF PLAINFIELD
2320 MICHAS DRIVE
PLAINFIELD, IL 60585
WILL
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
4,228,585
Income Statement
241,383
0
4,469,968
54,305
-3,110,205
-1,414,066
-4,469,966 -156.9%
36.2%
7.3
70.2
10.0%
36.7%
Key Performanace Ind.
77.9
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 4,922,754
100.0%
54.9%
45.1%
0.0%
0.0%
45.1%
Current Assets
Fixed Assets
4,922,754
2,703,873
2,218,881
-2
0
2,218,879
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142616
FRESENIUS MEDICAL CARE OF ROUND LAKE
401 NIPPERSINK AVENUE
ROUND LAKE, IL 60073
LAKE
NOVITAS (TEXAS)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
1,011,590
Income Statement
275,097
0
1,286,687
3,908,551
-1,482,508
-3,712,728
-1,286,685 -53.8%
10.9%
620.7
151.5
13.0%
39.6%
Key Performanace Ind.
0.3
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 4,296,269
100.0%
53.5%
46.5%
0.0%
0.0%
46.5%
Current Assets
Fixed Assets
4,296,269
2,298,334
1,997,935
0
0
1,997,935
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 69
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142692
FRESENIUS MEDICAL CARE OF UPTOWN
4700 NORTH MARINE DRIVE
CHICAGO, IL 60640
COOK
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
4,820,758
Income Statement
254,120
50,625
5,125,503
-264,017
-1,184,875
-3,676,612
-5,125,504 -35.7%
34.9%
(34.5)
46.9
6.9%
34.9%
Key Performanace Ind.
(18.3)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 4,103,257
100.0%
68.1%
31.9%
0.0%
0.0%
31.9%
Current Assets
Fixed Assets
4,103,257
2,792,309
1,310,948
1
0
1,310,949
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142677
FRESENIUS MEDICAL CARE OSWEGO
1051 STATION DRIVE
OSWEGO, IL 60543
KENDALL
NOVITAS (TEXAS)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
7,591,659
Income Statement
1,126,915
9,090
8,727,664
-166,752
-784,361
-7,776,549
-8,727,662 -16.8%
24.0%
(22.1)
58.5
7.5%
31.8%
Key Performanace Ind.
(45.5)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 4,056,486
100.0%
67.9%
32.1%
0.0%
0.0%
32.1%
Current Assets
Fixed Assets
4,056,486
2,752,498
1,303,988
-1
0
1,303,987
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 70
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142576
FRESENIUS MEDICAL CARE OTTAWA
1601 MERCURY CIRCLE
OTTAWA, IL 61350
LA SALLE
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
2,959,614
Income Statement
46,196
11,358
3,017,168
-124,145
-513,868
-2,379,156
-3,017,169 -21.7%
15.5%
(28.4)
51.6
10.1%
35.1%
Key Performanace Ind.
(23.8)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 2,110,138
100.0%
75.6%
24.4%
0.0%
0.0%
24.4%
Current Assets
Fixed Assets
2,110,138
1,594,476
515,662
0
0
515,662
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142723
FRESENIUS MEDICAL CARE PALATINE
691 EAST DUNDEE ROAD
PALATINE, IL 60074
COOK
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
6,174,885
Income Statement
575,525
43,181
6,793,591
-2,106,396
-3,427,833
-1,259,362
-6,793,591 -372.8%
27.6%
(210.9)
248.6
10.5%
33.2%
Key Performanace Ind.
(2.9)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 8,339,713
100.0%
43.7%
56.3%
0.0%
0.0%
56.3%
Current Assets
Fixed Assets
8,339,713
3,644,779
4,694,934
0
0
4,694,934
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 71
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142596
FRESENIUS MEDICAL CARE PLAINFIELD NORTH
24024 WEST RIVERWALK COURT
PLAINFIELD, IL 60544
WILL
CGS (KENTUCKY)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
-635,227
Income Statement
1,093,718
0
458,491
-193,830
-113,552
-151,106
-458,488 474.6%
39.2%
(42.3)
99.8
6.9%
30.0%
Key Performanace Ind.
3.3
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 957,052
100.0%
174.9%
-74.9%
0.0%
0.0%
-74.9%
Current Assets
Fixed Assets
957,052
1,674,144
-717,092
1
0
(717,091)
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142502
FRESENIUS MEDICAL CARE POLK
557 W POLK STREET
CHICAGO, IL 60607
COOK
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
674,784
Income Statement
130,118
6,042
810,944
10,985,161
-1,551,569
-10,244,536
-810,944 -14.4%
14.5%
1,336.1
86.2
7.9%
36.0%
Key Performanace Ind.
0.1
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 4,475,823
100.0%
67.0%
33.0%
0.0%
0.0%
33.0%
Current Assets
Fixed Assets
4,475,823
3,000,849
1,474,974
0
0
1,474,974
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 72
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142589
FRESENIUS MEDICAL CARE RANDOLPH COUNTY
102 MEMORIAL DRIVE
CHESTER, IL 62233
RANDOLPH
BLUE CROSS (TEXAS)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
2,702,405
Income Statement
54,833
1,000
2,758,238
-95,259
-867,446
-1,795,533
-2,758,238 -14.3%
10.7%
(38.1)
36.4
8.0%
35.8%
Key Performanace Ind.
(28.4)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 1,168,325
100.0%
78.1%
21.9%
0.0%
0.0%
21.9%
Current Assets
Fixed Assets
1,168,325
911,988
256,337
0
0
256,337
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142735
FRESENIUS MEDICAL CARE RIVER FOREST
103 FOREST AVENUE
RIVER FOREST, IL 60305
COOK
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
1,402,183
Income Statement
896,268
0
2,298,451
8,345,876
-2,162,130
-8,482,196
-2,298,450 -18.3%
28.7%
858.7
88.3
8.8%
34.2%
Key Performanace Ind.
0.2
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 5,100,983
100.0%
69.5%
30.5%
0.0%
0.0%
30.5%
Current Assets
Fixed Assets
5,100,983
3,547,616
1,553,367
-1
0
1,553,366
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 73
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142645
FRESENIUS MEDICAL CARE RIVER ROCK -DIXON
101 WEST 2ND STREET
DIXON, IL 61021
LEE
DUMMY FOR MEDICAID HHA
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
172,954
Income Statement
56,999
-1,732
228,221
20,758
-136,046
-112,932
-228,220 -219.8%
74.5%
13.4
113.8
4.4%
38.5%
Key Performanace Ind.
8.3
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 815,686
100.0%
69.6%
30.4%
0.0%
0.0%
30.4%
Current Assets
Fixed Assets
815,686
567,476
248,210
1
0
248,211
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142703
FRESENIUS MEDICAL CARE ROCK ISLAND
2623 17TH STREET
ROCK ISLAND, IL 61201
ROCK ISLAND
DUMMY FOR MEDICAID HHA
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
248,824
Income Statement
200,985
12,699
462,508
-469,092
-139,119
145,702
-462,509 23.0%
93.5%
(131.6)
113.3
6.3%
34.8%
Key Performanace Ind.
(0.5)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 1,334,169
100.0%
97.5%
2.5%
0.0%
0.0%
2.5%
Current Assets
Fixed Assets
1,334,169
1,300,713
33,456
-1
0
33,455
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 74
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142525
FRESENIUS MEDICAL CARE ROLLING MEADOWS
4180 WINNETKA ROAD
ROLLING MEADOWS, IL 60008
COOK
NOVITAS (TEXAS)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
890,126
Income Statement
110,517
8,942
1,009,585
10,202,786
-1,677,539
-9,534,831
-1,009,584 -29.8%
13.6%
1,231.7
97.3
9.8%
41.1%
Key Performanace Ind.
0.1
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 5,862,160
100.0%
51.6%
48.4%
0.0%
0.0%
48.4%
Current Assets
Fixed Assets
5,862,160
3,023,593
2,838,567
2
0
2,838,569
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142690
FRESENIUS MEDICAL CARE ROSELAND
132 W 111TH ST
CHICAGO, IL 60628
COOK
DUMMY FOR MEDICAID HHA
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
675,683
Income Statement
72,865
14,500
763,048
1,883,678
-763,576
-1,883,152
-763,050 -56.2%
25.2%
314.2
131.6
7.0%
37.5%
Key Performanace Ind.
0.4
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 3,245,941
100.0%
67.4%
32.6%
0.0%
0.0%
32.6%
Current Assets
Fixed Assets
3,245,941
2,187,930
1,058,011
0
0
1,058,011
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 75
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142700
FRESENIUS MEDICAL CARE SANDWICH
1310 NORTH MAIN STREET, SUITE 105
SANDWICH, IL 60548
DEKALB
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
2,391,584
Income Statement
228,807
14,500
2,634,891
-478,656
-441,787
-1,714,447
-2,634,890 -28.6%
22.5%
(115.3)
41.1
7.9%
36.3%
Key Performanace Ind.
(5.0)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 2,005,852
100.0%
75.6%
24.4%
0.0%
0.0%
24.4%
Current Assets
Fixed Assets
2,005,852
1,515,597
490,255
1
0
490,256
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142675
FRESENIUS MEDICAL CARE SILVIS
880 CROSSTOWN AVE
SILVIS, IL 61282
ROCK ISLAND
DUMMY FOR MEDICAID HHA
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
403,817
Income Statement
186,152
17,692
607,661
637,339
-291,442
-953,557
-607,660 -94.1%
111.2%
124.8
94.3
7.2%
35.8%
Key Performanace Ind.
0.6
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 2,761,652
100.0%
67.5%
32.5%
0.0%
0.0%
32.5%
Current Assets
Fixed Assets
2,761,652
1,864,540
897,112
-1
0
897,111
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 76
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142519
FRESENIUS MEDICAL CARE SOUTH CHICAGO
9200 SOUTH CHICAGO
CHICAGO, IL 60617
COOK
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
1,843,672
Income Statement
1,032,734
17,133
2,893,539
9,322,333
-2,730,877
-9,484,994
-2,893,538 -35.0%
12.2%
552.6
192.2
9.8%
41.3%
Key Performanace Ind.
0.2
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 9,481,898
100.0%
64.9%
35.1%
0.0%
0.0%
35.1%
Current Assets
Fixed Assets
9,481,898
6,157,443
3,324,455
0
0
3,324,455
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142756
FRESENIUS MEDICAL CARE SOUTH DEERING
10559 S TORRENCE AVE
CHICAGO, IL 60617
COOK
DUMMY FOR MEDICAID HHA
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
1,375,227
Income Statement
1,092,317
3,657
2,471,201
-290,338
-686,709
-1,494,153
-2,471,200 -60.4%
15.7%
(43.9)
48.6
8.2%
37.7%
Key Performanace Ind.
(4.7)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 3,314,581
100.0%
72.8%
27.2%
0.0%
0.0%
27.2%
Current Assets
Fixed Assets
3,314,581
2,412,763
901,818
-1
0
901,817
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 77
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142542
FRESENIUS MEDICAL CARE SOUTH HOLLAND
17225 S PAXTON AVE
SOUTH HOLLAND, IL 60473
COOK
TRAILBLAZER (TEXAS)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
1,422,881
Income Statement
880,761
0
2,303,642
12,442,248
-3,458,670
-11,287,220
-2,303,642 -39.4%
25.6%
892.5
97.2
8.9%
37.5%
Key Performanace Ind.
0.1
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 9,531,441
100.0%
53.4%
46.6%
0.0%
0.0%
46.6%
Current Assets
Fixed Assets
9,531,441
5,088,347
4,443,094
0
0
4,443,094
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142572
FRESENIUS MEDICAL CARE SOUTH SHORE
2420 EAST 79TH STREET
CHICAGO, IL 60649
COOK
NOVITAS (TEXAS)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
438,111
Income Statement
176,894
0
615,005
635,411
-432,947
-817,469
-615,005 -11.3%
26.4%
130.1
138.0
7.3%
36.4%
Key Performanace Ind.
0.7
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 1,874,929
100.0%
95.1%
4.9%
0.0%
0.0%
4.9%
Current Assets
Fixed Assets
1,874,929
1,782,924
92,005
1
0
92,006
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 78
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142725
FRESENIUS MEDICAL CARE STEGER
219 E 34TH STREET
STEGER, IL 60475
COOK
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
1,075,426
Income Statement
738,594
15,405
1,829,425
-155,333
-339,463
-1,334,629
-1,829,425 -12.4%
19.7%
(24.2)
143.9
8.3%
34.4%
Key Performanace Ind.
(6.9)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 2,504,169
100.0%
93.4%
6.6%
0.0%
0.0%
6.6%
Current Assets
Fixed Assets
2,504,169
2,338,405
165,764
-1
0
165,763
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142695
FRESENIUS MEDICAL CARE STREATOR
2356 NORTH BLOOMINGTON STREET
STREATOR, IL 61364
LA SALLE
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
-705,389
Income Statement
74,434
14,500
-616,455
-33,844
-136,414
786,713
616,455 13.3%
16.7%
(11.0)
75.3
6.9%
33.2%
Key Performanace Ind.
20.8
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 1,231,080
100.0%
91.5%
8.5%
0.0%
0.0%
8.5%
Current Assets
Fixed Assets
1,231,080
1,126,323
104,757
1
0
104,758
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 79
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142802
FRESENIUS MEDICAL CARE SUMMIT
7320 ARCHER AVE
SUMMIT, IL 60501
COOK
DUMMY FOR MEDICAID HHA
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
288,531
Income Statement
316,842
0
605,373
-1,357,924
-309,984
1,062,533
-605,375 -52.0%
146.2%
(355.5)
100.0
5.0%
28.7%
Key Performanace Ind.
(0.2)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 841,892
100.0%
165.6%
-65.6%
0.0%
0.0%
-65.6%
Current Assets
Fixed Assets
841,892
1,394,269
-552,377
0
0
(552,377)
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142727
FRESENIUS MEDICAL CARE WAUKEGAN HARBOR
110 NORTH WEST STREET
WAUKEGAN, IL 60085
LAKE
DUMMY FOR MEDICAID HHA
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
1,292,909
Income Statement
658,597
0
1,951,506
10,366,336
-3,795,644
-8,522,199
-1,951,507 -54.1%
16.5%
1,118.5
106.6
10.2%
40.0%
Key Performanace Ind.
0.1
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 7,991,731
100.0%
42.3%
57.7%
0.0%
0.0%
57.7%
Current Assets
Fixed Assets
7,991,731
3,382,950
4,608,781
-1
0
4,608,780
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 80
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142523
FRESENIUS MEDICAL CARE WEST BELMONT
4943 WEST BELMONT
CHICAGO, IL 60641
COOK
NOVITAS (TEXAS)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
970,963
Income Statement
266,475
0
1,237,438
11,705,836
-4,289,595
-8,653,679
-1,237,438 -36.2%
26.1%
1,561.3
101.7
9.8%
37.3%
Key Performanace Ind.
0.1
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 5,872,857
100.0%
46.6%
53.4%
0.0%
0.0%
53.4%
Current Assets
Fixed Assets
5,872,857
2,736,562
3,136,295
-1
0
3,136,294
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142702
FRESENIUS MEDICAL CARE WEST CHICAGO
1859 NELTOR BLVD
WEST CHICAGO, IL 60185
DUPAGE
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
2,498,689
Income Statement
111,461
0
2,610,150
-136,453
-652,702
-1,820,995
-2,610,150 -57.5%
34.9%
(24.5)
49.1
7.4%
38.3%
Key Performanace Ind.
(18.3)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 3,082,492
100.0%
66.1%
33.9%
0.0%
0.0%
33.9%
Current Assets
Fixed Assets
3,082,492
2,036,283
1,046,209
0
0
1,046,209
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 81
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142780
FRESENIUS MEDICAL CARE WEST FRANKFORT
5 WEST FRANKFORT PLAZA
WEST FRANKFORT, IL 62896
FRANKLIN
NGS (IL)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
646,718
Income Statement
525,002
0
1,171,720
-113,393
-233,583
-824,744
-1,171,720 -74.0%
13.2%
(99.2)
52.0
2.3%
30.8%
Key Performanace Ind.
(5.7)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 1,027,663
100.0%
40.6%
59.4%
0.0%
0.0%
59.4%
Current Assets
Fixed Assets
1,027,663
417,377
610,286
0
0
610,286
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142530
FRESENIUS MEDICAL CARE WEST SUBURBAN
518 N AUSTIN
OAK PARK, IL 60302
COOK
BLUE CROSS (TEXAS)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
38,237,158
Income Statement
703,331
3,034
38,943,523
-1,205,166
-1,968,437
-35,769,920
-38,943,523 -10.5%
21.9%
(61.3)
95.2
11.0%
40.3%
Key Performanace Ind.
(31.7)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 10,935,159
100.0%
65.6%
34.4%
0.0%
0.0%
34.4%
Current Assets
Fixed Assets
10,935,159
7,177,889
3,757,270
0
0
3,757,270
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 82
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142730
FRESENIUS MEDICAL CARE WEST WILLOW
1444 WEST WILLOW
CHICAGO, IL 60642
COOK
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
555,842
Income Statement
529,213
0
1,085,055
-265,086
-699,738
-120,232
-1,085,056 -191.7%
19.6%
(58.1)
57.2
7.9%
37.4%
Key Performanace Ind.
(2.1)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 1,894,736
100.0%
87.8%
12.2%
0.0%
0.0%
12.2%
Current Assets
Fixed Assets
1,894,736
1,664,253
230,483
0
0
230,483
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142627
FRESENIUS MEDICAL CARE WILLIAMSON COUNTY
900 SKYLINE DRIVE, SUITE 200
MARION, IL 62959
WILLIAMSON
BLUE CROSS (TEXAS)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
5,792,109
Income Statement
85,265
11,680
5,889,054
-150,692
-45,835
-5,692,526
-5,889,053 -20.3%
5.2%
(31.1)
78.9
9.6%
35.4%
Key Performanace Ind.
(38.4)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 2,923,860
100.0%
60.4%
39.6%
0.0%
0.0%
39.6%
Current Assets
Fixed Assets
2,923,860
1,766,267
1,157,593
-1
0
1,157,592
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 83
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142777
GARFIELD KIDNEY CENTER
3250 W FRANKLIN BLVD
CHICAGO, IL 60624
COOK
DUMMY FOR MEDICAID HHA
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
-1,218,664
Income Statement
494,841
2,761,269
2,037,446
878,656
0
1,158,789
2,037,445 44.2%
7.7%
3.8
161.3
5.4%
33.0%
Key Performanace Ind.
(1.4)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
7.7%359,579Contract Allowance
Total Charges 4,695,758
92.3%
88.4%
11.6%
0.2%
0.0%
11.8%
Current Assets
Fixed Assets
4,336,179
3,831,685
504,494
8,230
0
512,724
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142551
GLENVIEW DIALYSIS CENTER
4248 COMMERCIAL WAY
GLENVIEW, IL 60025
COOK
BLUE CROSS (TEXAS)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
13,792,354
Income Statement
898,155
12,037
14,702,546
-232,982
-2,047,528
-12,422,037
-14,702,547 -10.6%
17.5%
(31.8)
74.7
10.3%
35.9%
Key Performanace Ind.
(59.2)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 3,986,662
100.0%
67.0%
33.0%
0.0%
0.0%
33.0%
Current Assets
Fixed Assets
3,986,662
2,671,278
1,315,384
0
0
1,315,384
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 84
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142728
GRAND CROSSING DIALYSIS
7319 S COTTAGE GROVE AVE
CHICAGO, IL 60619
COOK
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
22,555
Income Statement
502,248
0
524,803
736,407
10,808
-222,410
524,805 105.5%
12.6%
2.5
167.4
5.0%
33.6%
Key Performanace Ind.
0.0
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-3.2%-84,494Contract Allowance
Total Charges 2,634,179
103.2%
109.5%
-9.5%
0.9%
0.0%
-8.6%
Current Assets
Fixed Assets
2,718,673
2,976,522
-257,849
23,130
0
(234,719)
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142786
HARRISBURG HOME TRAINING
303 S COMMERCIAL STREET, SUITE 15
HARRISBURG, IL 62946
SALINE
DUMMY FOR MEDICAID HHA
10/23/2017 296 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
263,554
Income Statement
219,763
0
483,317
1,338
0
481,980
483,318 -22.6%
13.2%
0.0
138.3
1.7%
23.0%
Key Performanace Ind.
197.0
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
5.2%16,850Contract Allowance
Total Charges 325,097
94.8%
150.1%
-50.1%
14.9%
0.0%
-35.3%
Current Assets
Fixed Assets
308,247
462,781
-154,534
45,846
0
(108,688)
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 85
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142698
HARVEY DIALYSIS
16641 HALSTED ST
HARVEY, IL 60426
COOK
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
-4,136,266
Income Statement
648,363
3,523,152
35,249
418,626
5,103
-388,480
35,249 -9.3%
21.0%
4.5
251.8
5.1%
32.4%
Key Performanace Ind.
(9.9)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
5.5%173,812Contract Allowance
Total Charges 3,149,568
94.5%
99.0%
1.0%
0.2%
0.0%
1.2%
Current Assets
Fixed Assets
2,975,756
2,945,563
30,193
5,843
0
36,036
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142622
HAZEL CREST RENAL CENTER
3470 W 183RD STREET
HAZEL CREST, IL 60429
COOK
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
17,099,939
Income Statement
166,130
-7,030
17,259,039
1,207,016
7,612
16,044,412
17,259,040 9.4%
13.3%
7.0
155.4
5.8%
32.8%
Key Performanace Ind.
14.2
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-1.0%-55,496Contract Allowance
Total Charges 5,481,081
101.0%
72.8%
27.2%
0.2%
0.0%
27.4%
Current Assets
Fixed Assets
5,536,577
4,030,996
1,505,581
9,653
0
1,515,234
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 86
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142694
HOME DIALYSIS NETWORK, INC
95 INFANTRY DRIVE
JOLIET, IL 60435
WILL
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
2,061,991
Income Statement
232,072
2,566,739
4,860,802
-438,352
-576,209
-3,846,240
-4,860,801 -8.8%
35.2%
(126.9)
66.5
5.1%
28.6%
Key Performanace Ind.
(4.7)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 1,599,782
100.0%
78.8%
21.2%
0.0%
0.0%
21.2%
Current Assets
Fixed Assets
1,599,782
1,260,518
339,264
2
0
339,266
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142760
HOME DIALYSIS SERVICE ELGIN, LLC
440 N IL RT 31
CRYSTAL LAKE, IL 60012
MCHENRY
NGS (IL)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
3,260,285
Income Statement
64,120
48,000
3,372,405
3,140,171
0
232,234
3,372,405 279.2%
66.7%
554.0
237.2
2.5%
22.4%
Key Performanace Ind.
1.0
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
93.0%31,030,929Contract Allowance
Total Charges 33,354,852
7.0%
73.5%
26.5%
1.4%
0.0%
27.9%
Current Assets
Fixed Assets
2,323,923
1,708,995
614,928
33,460
0
648,388
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 87
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142799
HOME DIALYSIS SERVICES ELK GROVE, LLC
1843 W IRVING PARK RD
SCHAUMBURG, IL 60193
COOK
DUMMY FOR MEDICAID HHA
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
441,755
Income Statement
2,538
0
444,293
445,874
0
-1,581
444,293 -19,425.0
%
2,091.9%
180.7
136.9
3.7%
35.6%
Key Performanace Ind.
1.0
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
30.1%495,940Contract Allowance
Total Charges 1,646,371
69.9%
73.3%
26.7%
0.0%
0.0%
26.7%
Current Assets
Fixed Assets
1,150,431
843,321
307,110
0
0
307,110
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142801
HOME DIALYSIS SERVICES FRANKFORT, LLC
7777 W LINCOLN HWY
FRANKFORT, IL 60423
WILL
DUMMY FOR MEDICAID HHA
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
14,864
Income Statement
99,053
0
113,917
41,668
0
72,249
113,917 251.3%
30.7%
0.0
6.0
2.3%
29.8%
Key Performanace Ind.
0.4
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 906,444
100.0%
80.0%
20.0%
0.0%
0.0%
20.0%
Current Assets
Fixed Assets
906,444
724,907
181,537
0
0
181,537
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 88
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142761
HOME DIALYSIS SERVICES HICKORY HILLS
7831 W 95TH ST, SUITE C
HICKORY HILLS, IL 60457
COOK
DUMMY FOR MEDICAID HHA
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
2,804,912
Income Statement
30,008
0
2,834,920
2,711,823
0
123,097
2,834,920 745.0%
65.1%
685.8
133.2
2.2%
32.7%
Key Performanace Ind.
1.0
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 2,306,671
100.0%
60.2%
39.8%
0.0%
0.0%
39.8%
Current Assets
Fixed Assets
2,306,671
1,389,567
917,104
0
0
917,104
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142800
HOME DIALYSIS SERVICES NORTH CHICAGO, LLC
7315 W NORTH AVENUE
RIVER FOREST, IL 60305
COOK
DUMMY FOR MEDICAID HHA
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
75,173
Income Statement
22,890
3,035
101,098
362,541
0
-261,443
101,098 82.7%
110.9%
1.9
97.3
4.7%
46.2%
Key Performanace Ind.
0.2
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 281,869
100.0%
176.7%
-76.7%
0.0%
0.0%
-76.7%
Current Assets
Fixed Assets
281,869
498,151
-216,282
0
0
(216,282)
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 89
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142769
HOME DIALYSIS SERVICES OLYMPIA FIELDS
3322 VOLLMER RD, SUITE A
OLYMPIA FIELDS, IL 60461
COOK
DUMMY FOR MEDICAID HHA
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
401,008
Income Statement
29,066
0
430,074
368,204
0
61,870
430,074 888.6%
256.3%
63.3
63.1
1.9%
23.5%
Key Performanace Ind.
1.1
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
81.7%10,244,756Contract Allowance
Total Charges 12,546,081
18.3%
76.2%
23.8%
0.1%
0.0%
23.9%
Current Assets
Fixed Assets
2,301,325
1,753,430
547,895
1,881
0
549,776
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142788
HOME DIALYSIS SERVICES PEORIA, LLC
719 MAIN ST
PEORIA, IL 61602
PEORIA
DUMMY FOR MEDICAID HHA
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
367,458
Income Statement
0
0
367,458
493,741
0
-126,283
367,458 24.3%
0.0%
(40.8)
158.1
5.7%
34.9%
Key Performanace Ind.
0.7
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 833,975
100.0%
103.7%
-3.7%
0.0%
0.0%
-3.7%
Current Assets
Fixed Assets
833,975
864,707
-30,732
0
0
(30,732)
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 90
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142792
HOME DIALYSIS SERVICES ROCKFORD, LLC
6940 VILLAGREEN VIEW
ROCKFORD, IL 61107
WINNEBAGO
DUMMY FOR MEDICAID HHA
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
1,333,403
Income Statement
89,470
0
1,422,873
1,247,904
0
174,969
1,422,873 407.3%
15.4%
488.7
308.0
2.0%
28.4%
Key Performanace Ind.
1.1
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
74.1%4,530,948Contract Allowance
Total Charges 6,110,994
25.9%
54.9%
45.1%
0.0%
0.0%
45.1%
Current Assets
Fixed Assets
1,580,046
867,356
712,690
0
0
712,690
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142745
HOME DIALYSIS SERVICES, LLC
15786 S BELL ROAD
HOMER GLEN, IL 60491
WILL
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
484,605
Income Statement
46,947
0
531,552
533,298
0
-1,746
531,552 -9,708.0%
55.2%
68.9
72.2
1.7%
25.7%
Key Performanace Ind.
0.9
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
1.8%42,966Contract Allowance
Total Charges 2,331,020
98.2%
92.6%
7.4%
0.0%
0.0%
7.4%
Current Assets
Fixed Assets
2,288,054
2,119,304
168,750
751
0
169,501
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 91
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142791
HOME HEMODIALYSIS NETWORK, LLC
14146 S BELL RD
HOMER GLEN, IL 60491
WILL
DUMMY FOR MEDICAID HHA
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
4,656,975
Income Statement
30,933
0
4,687,908
4,454,390
0
233,518
4,687,908 161.2%
146.9%
718.1
304.1
5.6%
26.1%
Key Performanace Ind.
1.0
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
83.8%13,060,416Contract Allowance
Total Charges 15,590,663
16.2%
87.0%
13.0%
1.9%
0.0%
14.9%
Current Assets
Fixed Assets
2,530,247
2,201,664
328,583
47,834
0
376,417
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142633
ILLINI RENAL DIALYSIS
507 EAST UNIVERSITY
CHAMPAIGN, IL 61820
CHAMPAIGN
CAHABA GBA (GA)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
13,176,169
Income Statement
134,745
48,567
13,359,481
407,951
1,767
12,949,764
13,359,482 7.4%
6.9%
3.0
105.6
4.3%
28.7%
Key Performanace Ind.
32.3
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-3.4%-139,244Contract Allowance
Total Charges 4,082,439
103.4%
77.3%
22.7%
0.1%
0.0%
22.8%
Current Assets
Fixed Assets
4,221,683
3,261,773
959,910
2,419
0
962,329
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 92
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142759
IROQUOIS KIDNEY CENTER, LLC
209 S 5TH ST
WATSEKA, IL 60970
IROQUOIS
DUMMY FOR MEDICAID HHA
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
25,026
Income Statement
7,334
6,915
39,275
1,091
0
38,184
39,275 79.4%
14.4%
1.4
29.5
1.1%
24.6%
Key Performanace Ind.
22.9
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 309,633
100.0%
90.2%
9.8%
0.0%
0.0%
9.8%
Current Assets
Fixed Assets
309,633
279,312
30,321
0
0
30,321
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142516
JACKSON PARK DIALYSIS CENTER
7531 S STONY ISLAND
CHICAGO, IL 60649
COOK
BLUE CROSS (TEXAS)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
2,423,745
Income Statement
364,890
9,425
2,798,060
-499,678
-625,520
-1,672,863
-2,798,061 -55.2%
13.2%
(50.5)
98.9
8.9%
42.0%
Key Performanace Ind.
(4.9)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 4,532,331
100.0%
79.6%
20.4%
0.0%
0.0%
20.4%
Current Assets
Fixed Assets
4,532,331
3,609,428
922,903
-1
0
922,902
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 93
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142636
JERSEYVILLE DIALYSIS CENTER
917 SOUTH STATE STREET
JERSEYVILLE, IL 62052
JERSEY
NGS (IL)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
-2,428,938
Income Statement
701,605
4,252,147
2,524,814
58,671
19,243
2,446,898
2,524,812 -2.2%
12.0%
6.7
218.8
4.8%
31.9%
Key Performanace Ind.
(41.4)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
2.2%33,415Contract Allowance
Total Charges 1,492,063
97.8%
103.7%
-3.7%
0.0%
0.0%
-3.7%
Current Assets
Fixed Assets
1,458,648
1,513,219
-54,571
264
0
(54,307)
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142313
JOHN H STROGER HOSPITAL
1901 WEST HARRISON, SUITE 2373
CHICAGO, IL 60612
COOK
NATIONAL GOVERNMENT SERVICES
Cost Report not filed.
Public
End Stage Renal Disease
Balance Sheet
0
Income Statement
0
0
0
0
0
0
0 0.0%
0.0%
0.0%
0.0%
Key Performanace Ind.
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 0
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Current Assets
Fixed Assets
0
0
0
0
0
0
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 94
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142776
JOLIET DIALYSIS HOLDINGS, LLC
368 S WEBER RD
ROMEOVILLE, IL 60446
WILL
DUMMY FOR MEDICAID HHA
12/31/2017 365 Days Settled
Not for Profit
End Stage Renal Disease
Balance Sheet
46,024
Income Statement
52,135
0
98,159
70,730
0
27,429
98,159 2,064.6%
25.7%
0.0
1.6
0.0%
25.7%
Key Performanace Ind.
0.7
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 1,435,525
100.0%
60.6%
39.4%
0.0%
0.0%
39.4%
Current Assets
Fixed Assets
1,435,525
869,229
566,296
0
0
566,296
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142685
KANKAKEE COUNTY DIALYSIS
581 WILLIAM LATHAM DRIVE, SUITE 104
BOURBONNAIS, IL 60914
KANKAKEE
BLUE CROSS (TEXAS)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
5,553,986
Income Statement
232,337
22,422
5,808,745
920,827
9,649
4,878,270
5,808,746 17.8%
14.9%
7.9
89.4
4.4%
31.5%
Key Performanace Ind.
6.0
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-3.1%-124,935Contract Allowance
Total Charges 4,088,024
103.1%
79.5%
20.5%
0.1%
0.0%
20.6%
Current Assets
Fixed Assets
4,212,959
3,348,291
864,668
3,466
0
868,134
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 95
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142691
KENNEDY HOME DIALYSIS
5513 NORTH CUMBERLAND, SUITE 703
CHICAGO, IL 60656
COOK
Noridian (CA)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
-2,012,567
Income Statement
771,862
0
-1,240,705
15,523
0
-1,256,228
-1,240,705 37.9%
19.3%
4.2
114.2
1.4%
16.6%
Key Performanace Ind.
(129.7)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-6.9%-3,656Contract Allowance
Total Charges 52,809
106.9%
943.1%
-843.1%
0.0%
0.0%
-843.1%
Current Assets
Fixed Assets
56,465
532,520
-476,055
0
0
(476,055)
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142717
KENWOOD DIALYSIS
4259 S COTTAGE GROVE AVE
CHICAGO, IL 60653
COOK
NGS (IL)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
-6,100,933
Income Statement
1,513,189
7,022,475
2,434,731
1,079,701
238,538
1,116,491
2,434,730 -2.5%
19.4%
9.1
172.9
5.5%
29.0%
Key Performanace Ind.
(5.7)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-2.1%-117,284Contract Allowance
Total Charges 5,588,308
102.1%
100.6%
-0.6%
0.1%
0.0%
-0.5%
Current Assets
Fixed Assets
5,705,592
5,741,681
-36,089
8,495
0
(27,594)
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 96
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142720
KENWOOD HOME DIALYSIS
4259 S COTTAGE GROVE AVE
CHICAGO, IL 60653
COOK
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
6,653,183
Income Statement
531,879
5,987,913
13,172,975
1,438,977
80,219
11,653,778
13,172,974 11.7%
22.9%
4.0
263.9
2.8%
19.5%
Key Performanace Ind.
4.6
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
2.8%118,459Contract Allowance
Total Charges 4,177,300
97.2%
67.7%
32.3%
1.2%
0.0%
33.5%
Current Assets
Fixed Assets
4,058,841
2,749,688
1,309,153
49,881
0
1,359,034
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142666
LAKE VILLA DIALYSIS
37809 N ROUTE 59
LAKE VILLA, IL 60046
LAKE
BLUE CROSS (TEXAS)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
4,230,623
Income Statement
217,109
30,000
4,477,732
939,072
20,062
3,518,597
4,477,731 20.2%
13.0%
5.5
110.0
4.2%
31.3%
Key Performanace Ind.
4.5
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-4.2%-128,641Contract Allowance
Total Charges 3,035,077
104.2%
77.6%
22.4%
0.0%
0.0%
22.4%
Current Assets
Fixed Assets
3,163,718
2,454,931
708,787
272
0
709,059
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 97
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142724
LAKEVIEW HOME DIALYSIS LLC
3023 NORTH ASHLAND AVE SUITE 1
CHICAGO, IL 60657
COOK
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
43,339
Income Statement
0
9,100
52,439
194
0
52,245
52,439 697.7%
138.6%
0.1
10.7
0.8%
33.8%
Key Performanace Ind.
223.4
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
41.2%634,105Contract Allowance
Total Charges 1,540,027
58.8%
61.0%
39.0%
1.3%
0.0%
40.2%
Current Assets
Fixed Assets
905,922
552,868
353,054
11,458
0
364,512
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142768
LAWNDALE DIALYSIS
3934 W 24TH ST
CHICAGO, IL 60623
COOK
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
2,644,110
Income Statement
919,914
0
3,564,024
1,342,551
247,521
1,973,951
3,564,023 18.7%
17.9%
9.0
209.8
5.4%
28.2%
Key Performanace Ind.
2.0
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-1.0%-44,534Contract Allowance
Total Charges 4,644,136
101.0%
84.7%
15.3%
-7.4%
0.0%
7.9%
Current Assets
Fixed Assets
4,688,670
3,972,967
715,703
-347,244
0
368,459
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 98
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142528
LINCOLN PARK DIALYSIS
2484 N ELSTON AVE
CHICAGO, IL 60647
COOK
BLUE CROSS (CALIFORNIA)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
15,522,209
Income Statement
2,362,456
73,855
17,958,520
606,416
78,156
17,273,948
17,958,520 2.6%
27.2%
6.8
138.5
3.9%
25.3%
Key Performanace Ind.
25.6
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-13.2%-647,405Contract Allowance
Total Charges 4,888,618
113.2%
92.1%
7.9%
0.2%
0.0%
8.1%
Current Assets
Fixed Assets
5,536,023
5,096,270
439,753
9,810
0
449,563
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142668
LITTLE VILLAGE DIALYSIS
2335 W CERMAK ROAD
CHICAGO, IL 60608
COOK
BLUE CROSS (TEXAS)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
10,292,910
Income Statement
651,065
10,425
10,954,400
2,433,403
38,928
8,482,070
10,954,401 17.8%
12.6%
3.2
142.9
4.5%
28.6%
Key Performanace Ind.
4.2
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
5.1%303,494Contract Allowance
Total Charges 5,929,398
94.9%
73.3%
26.7%
0.1%
0.0%
26.8%
Current Assets
Fixed Assets
5,625,904
4,125,512
1,500,392
6,631
0
1,507,023
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 99
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142329
LOYOLA CENTER FOR DIALYSIS ROOSEVELT
1201 W ROOSEVELT RD
MAYWOOD, IL 60153
COOK
NATIONAL GOVERNMENT SERVICES
Cost Report not filed.
Not for Profit
End Stage Renal Disease
Balance Sheet
0
Income Statement
0
0
0
0
0
0
0 0.0%
0.0%
0.0%
0.0%
Key Performanace Ind.
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 0
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Current Assets
Fixed Assets
0
0
0
0
0
0
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142806
MACHESNEY PARK DIALYSIS
7101 N PERRYVILLE RD
MACHESNEY PARK, IL 61115
WINNEBAGO
NGS (IL)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
660,928
Income Statement
1,360,633
0
2,021,561
189,446
62,764
1,769,352
2,021,562 -9.4%
15.2%
4.6
118.8
4.3%
28.7%
Key Performanace Ind.
3.5
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
1.8%26,316Contract Allowance
Total Charges 1,445,834
98.2%
114.6%
-14.6%
2.9%
0.0%
-11.7%
Current Assets
Fixed Assets
1,419,518
1,626,222
-206,704
40,871
0
(165,833)
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 100
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142584
MACON COUNTY DIALYSIS
1090 W MCKINLEY
DECATUR, IL 62526
MACON
BLUE CROSS (GEORGIA)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
9,389,936
Income Statement
335,793
2,738,909
12,464,638
124,466
22,243
12,317,930
12,464,639 3.4%
20.6%
3.9
133.4
5.1%
29.4%
Key Performanace Ind.
75.4
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-5.8%-173,072Contract Allowance
Total Charges 2,993,721
105.8%
86.9%
13.1%
0.1%
0.0%
13.3%
Current Assets
Fixed Assets
3,166,793
2,750,362
416,431
4,172
0
420,603
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142671
MANTENO DIALYSIS CENTRE
1 EAST DIVISION STREET
MANTENO, IL 60950
KANKAKEE
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
789,515
Income Statement
100,488
0
890,003
579,472
0
310,531
890,003 61.6%
5.1%
78.1
28.8
8.4%
52.4%
Key Performanace Ind.
1.4
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 2,312,338
100.0%
91.7%
8.3%
0.0%
0.0%
8.3%
Current Assets
Fixed Assets
2,312,338
2,121,090
191,248
0
0
191,248
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 101
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142644
MAPLE AVENUE KIDNEY CENTER
610 S MAPLE AVENUE
OAK PARK, IL 60304
COOK
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
1,580,101
Income Statement
235,023
0
1,815,124
320,166
0
1,494,958
1,815,124 5.7%
13.1%
0.0
30.4
2.8%
27.4%
Key Performanace Ind.
4.9
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.4%10,831Contract Allowance
Total Charges 2,597,202
99.6%
96.7%
3.3%
0.0%
0.0%
3.3%
Current Assets
Fixed Assets
2,586,371
2,500,541
85,830
0
0
85,830
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142643
MARENGO CITY DIALYSIS
910 GREENLEE STREET SUITE B
MARENGO, IL 60152
MCHENRY
DUMMY FOR MEDICAID HHA
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
-1,207,201
Income Statement
796,841
1,175,037
764,677
222,853
11,296
530,527
764,676 7.7%
10.3%
6.6
126.0
4.3%
32.7%
Key Performanace Ind.
(5.4)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
5.0%73,382Contract Allowance
Total Charges 1,474,632
95.0%
97.1%
2.9%
0.0%
0.0%
2.9%
Current Assets
Fixed Assets
1,401,250
1,360,398
40,852
27
0
40,879
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 102
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142686
MARYVILLE HOME DIALYSIS
2102 VALALABENE DRIVE, SUITE B
MARYVILLE, IL 62062
MADISON
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
6,143,561
Income Statement
18,645
0
6,162,206
285,134
31,290
5,845,783
6,162,207 4.3%
10.0%
6.2
126.7
3.5%
24.1%
Key Performanace Ind.
21.5
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-42.6%-377,462Contract Allowance
Total Charges 886,221
142.6%
80.7%
19.3%
0.8%
0.0%
20.1%
Current Assets
Fixed Assets
1,263,683
1,020,415
243,268
10,491
0
253,759
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142805
MATTESON HOME TRAINING
4747 LINCOLN MALL DR, SUITE 225
MATTESON, IL 60443
COOK
NGS (IL)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
453,811
Income Statement
524,239
0
978,050
848,130
36,623
93,296
978,049 457.6%
25.7%
14.4
307.6
2.6%
17.9%
Key Performanace Ind.
0.5
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-51.1%-633,576Contract Allowance
Total Charges 1,238,745
151.1%
77.2%
22.8%
0.0%
0.0%
22.8%
Current Assets
Fixed Assets
1,872,321
1,445,605
426,716
230
0
426,946
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 103
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142794
MEDICAL DISTRICT HOME DIALYSIS LLC
1111 S WESTERN AVE
CHICAGO, IL 60612
COOK
DUMMY FOR MEDICAID HHA
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
843,000
Income Statement
12,000
0
855,000
911,000
432,000
-488,000
855,000 56.9%
470.4%
69.4
79.2
0.0%
16.3%
Key Performanace Ind.
0.9
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 1,457,103
100.0%
119.0%
-19.0%
0.0%
0.0%
-19.0%
Current Assets
Fixed Assets
1,457,103
1,734,573
-277,470
0
0
(277,470)
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142315
MEMORIAL MEDICAL CENTER
701 NORTH FIRST ST
SPRINGFIELD, IL 62781
SANGAMON
NATIONAL GOVERNMENT SERVICES
Cost Report not filed.
Not for Profit
End Stage Renal Disease
Balance Sheet
0
Income Statement
0
0
0
0
0
0
0 0.0%
0.0%
0.0%
0.0%
Key Performanace Ind.
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 0
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Current Assets
Fixed Assets
0
0
0
0
0
0
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 104
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142611
MIDWEST KIDNEY CENTER - PONTIAC
804 W MADISON STREET
PONTIAC, IL 61764
LIVINGSTON
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
5,142,769
Income Statement
109,849
10,690
5,263,308
-104,215
-255,427
-4,903,666
-5,263,308 -3.2%
22.1%
(38.1)
89.1
6.9%
40.4%
Key Performanace Ind.
(49.3)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 1,154,400
100.0%
86.6%
13.4%
0.0%
0.0%
13.4%
Current Assets
Fixed Assets
1,154,400
999,471
154,929
1
0
154,930
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142603
MIDWEST KIDNEY CENTER DECATUR
1830 S 44TH STREET
DECATUR, IL 62521
MACON
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
2,044,179
Income Statement
94,658
7,250
2,146,087
-112,828
-301,461
-1,731,799
-2,146,088 -32.2%
32.9%
(24.9)
42.9
6.4%
38.8%
Key Performanace Ind.
(18.1)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 2,211,538
100.0%
74.8%
25.2%
0.0%
0.0%
25.2%
Current Assets
Fixed Assets
2,211,538
1,653,735
557,803
1
0
557,804
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 105
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142564
MIDWEST KIDNEY CENTER SPRING VALLEY
12 WOLFER DRIVE INDUSTRIAL PARK
SPRING VALLEY, IL 61362
BUREAU
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
9,433,422
Income Statement
114,233
13,050
9,560,705
-196,162
-852,140
-8,512,402
-9,560,704 -9.5%
12.5%
(34.0)
233.2
10.1%
36.4%
Key Performanace Ind.
(48.1)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 2,914,626
100.0%
72.3%
27.7%
0.0%
0.0%
27.7%
Current Assets
Fixed Assets
2,914,626
2,108,629
805,997
0
0
805,997
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142784
MIDWEST KIDNEY CENTER, LLC
8632 S PULASKI ROAD
CHICAGO, IL 60652
COOK
NGS (IL)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
487,681
Income Statement
1,700
0
489,381
0
455,391
33,990
489,381 326.2%
1,647.9%
0.0
3.1
1.6%
35.2%
Key Performanace Ind.
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 416,067
100.0%
73.4%
26.6%
0.0%
0.0%
26.6%
Current Assets
Fixed Assets
416,067
305,199
110,868
0
0
110,868
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 106
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142591
MMB DIALYSIS LLC
523 E GRANT STREET
MACOMB, IL 61455
MCDONOUGH
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
741,622
Income Statement
956,864
161,910
1,860,396
-239,367
-190,492
-1,430,538
-1,860,397 -19.0%
5.5%
(130.1)
43.2
6.0%
43.0%
Key Performanace Ind.
(3.1)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 944,208
100.0%
71.2%
28.8%
0.0%
0.0%
28.9%
Current Assets
Fixed Assets
944,208
671,804
272,404
2
0
272,406
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142762
MOLINE HOME TRAINING
4650 38TH AVE
MOLINE, IL 61265
ROCK ISLAND
DUMMY FOR MEDICAID HHA
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
710,406
Income Statement
104,994
0
815,400
323,722
0
491,678
815,400 31.2%
9.6%
0.2
95.7
2.0%
15.9%
Key Performanace Ind.
2.2
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
2.1%16,974Contract Allowance
Total Charges 820,069
97.9%
62.5%
37.5%
-18.4%
0.0%
19.1%
Current Assets
Fixed Assets
803,095
502,057
301,038
-147,509
0
153,529
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 107
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142813
MONTGOMERY COUNTY DIALYSIS
1822 SENATOR MILLER DR
HILLSBORO, IL 62049
MONTGOMERY
DUMMY FOR MEDICAID HHA
12/31/2017 320 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
-415,069
Income Statement
-151,719
0
-566,788
5,832
-20,095
-552,523
-566,786 100.0%
2,914.9%
1.3
1,251.4
2.7%
21.3%
Key Performanace Ind.
(71.2)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
11.1%114,056Contract Allowance
Total Charges 1,029,622
88.9%
160.3%
-60.3%
0.0%
0.0%
-60.3%
Current Assets
Fixed Assets
915,566
1,468,088
-552,522
0
0
(552,522)
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142814
MORRIS COMMUNITY DIALYSIS
1401 LAKEWOOD DR
MORRIS, IL 60450
GRUNDY
NGS (IL)
12/31/2017 265 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
157,507
Income Statement
110,781
28,418
296,706
114,476
59,312
122,918
296,706 -52.2%
24.0%
30.1
(56.5)
6.0%
41.3%
Key Performanace Ind.
1.4
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 474,661
100.0%
113.5%
-13.5%
0.0%
0.0%
-13.5%
Current Assets
Fixed Assets
474,661
538,775
-64,114
0
0
(64,114)
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 108
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142740
MORRIS DIALYSIS
1551 CREEK DRIVE
MORRIS, IL 60450
GRUNDY
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
-919,178
Income Statement
117,734
1,550,301
748,857
90,760
3,982
654,115
748,857 -45.1%
87.6%
7.9
86.7
5.5%
32.7%
Key Performanace Ind.
(10.1)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
2.4%40,906Contract Allowance
Total Charges 1,672,519
97.6%
118.1%
-18.1%
0.0%
0.0%
-18.1%
Current Assets
Fixed Assets
1,631,613
1,926,528
-294,915
76
0
(294,839)
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142541
MOUNT VERNON DIALYSIS
4102 N WATER TOWER PLACE
MOUNT VERNON, IL 62864
JEFFERSON
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
9,639,489
Income Statement
961,702
0
10,601,191
259,347
129,311
10,212,534
10,601,192 18.3%
14.6%
2.4
66.9
5.5%
24.9%
Key Performanace Ind.
37.2
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-24.3%-1,041,059Contract Allowance
Total Charges 4,280,682
124.3%
64.8%
35.2%
0.0%
0.0%
35.2%
Current Assets
Fixed Assets
5,321,741
3,447,948
1,873,793
-1,721
0
1,872,072
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 109
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142660
MT GREENWOOD DIALYSIS
3401 W 111TH ST
CHICAGO, IL 60655
COOK
BLUE CROSS (TEXAS)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
9,009,303
Income Statement
477,087
0
9,486,390
737,677
62,066
8,686,644
9,486,387 11.1%
8.4%
5.4
147.8
5.4%
32.0%
Key Performanace Ind.
12.2
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-6.6%-290,114Contract Allowance
Total Charges 4,404,180
106.6%
79.5%
20.5%
0.0%
0.0%
20.5%
Current Assets
Fixed Assets
4,694,294
3,733,741
960,553
-506
0
960,047
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142302
MT SINAI HOSPITAL MEDICAL CTR
15TH STREET AND CALIFORNIA
CHICAGO, IL 60608
COOK
NATIONAL GOVERNMENT SERVICES
Cost Report not filed.
Not for Profit
End Stage Renal Disease
Balance Sheet
0
Income Statement
0
0
0
0
0
0
0 0.0%
0.0%
0.0%
0.0%
Key Performanace Ind.
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 0
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Current Assets
Fixed Assets
0
0
0
0
0
0
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 110
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142600
NEPHRON DIALYSIS CTR LTD
5140 N CALIFORNIA AVE STE 510
CHICAGO, IL 60625
COOK
DUMMY FOR MEDICAID HHA
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
653,018
Income Statement
0
0
653,018
43,089
0
609,929
653,018 233.2%
6.7%
4.7
15.5
8.3%
57.9%
Key Performanace Ind.
15.2
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 4,692,494
100.0%
71.1%
28.9%
1.5%
0.0%
30.3%
Current Assets
Fixed Assets
4,692,494
3,338,431
1,354,063
68,589
0
1,422,652
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142785
NEW LENOX HOME TRAINING
1890 SILVER CROSS BLVD
NEW LENOX, IL 60451
WILL
NGS (IL)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
872,178
Income Statement
330,164
0
1,202,342
368,566
19,818
813,959
1,202,343 27.9%
22.9%
2.0
144.0
3.2%
23.0%
Key Performanace Ind.
2.4
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-3.2%-53,481Contract Allowance
Total Charges 1,663,669
103.2%
77.9%
22.1%
-8.9%
0.0%
13.2%
Current Assets
Fixed Assets
1,717,150
1,337,752
379,398
-152,589
0
226,809
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 111
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142797
NOCTURNAL DIALYSIS SPA
1634 ARDMORE AVE
VILLA PARK, IL 60181
DUPAGE
NGS (IL)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
-20,504
Income Statement
16,837
0
-3,667
942,181
0
-945,848
-3,667 30.8%
19.8%
0.0
(123.0)
0.9%
4.2%
Key Performanace Ind.
0.0
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 81,623
100.0%
457.0%
-357.0%
0.0%
0.0%
-357.0%
Current Assets
Fixed Assets
81,623
373,032
-291,409
0
0
(291,409)
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142811
NORTHSIDE HOME TRAINING
2550 W ADDISON, SUITE A4
CHICAGO, IL 60618
COOK
NGS (IL)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
656,086
Income Statement
890,801
0
1,546,887
100,145
164,514
1,282,225
1,546,884 -0.1%
16.4%
0.8
213.6
2.2%
16.6%
Key Performanace Ind.
6.6
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-2.2%-22,725Contract Allowance
Total Charges 1,015,866
102.2%
100.0%
0.0%
-0.1%
0.0%
-0.2%
Current Assets
Fixed Assets
1,038,591
1,039,101
-510
-1,165
0
(1,675)
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 112
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142770
NORTHWESTERN MEDICAL FACULTY FOUNDATION DIALYSIS
201 E HURON STREET, SUITE 12-240 GALTER PAVILION
CHICAGO, IL 60611
COOK
DUMMY FOR MEDICAID HHA
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
4,040,989
Income Statement
28,549
0
4,069,538
3,108,576
-103,447
1,064,409
4,069,538 47.1%
208.3%
10.1
141.7
2.0%
15.2%
Key Performanace Ind.
1.3
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
96.1%152,689,834Contract Allowance
Total Charges 158,842,936
3.9%
91.9%
8.1%
0.0%
0.0%
8.1%
Current Assets
Fixed Assets
6,153,102
5,651,998
501,104
0
0
501,104
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142779
NXSTAGE OAK BROOK, LLC
1600 W 16TH ST
OAK BROOK, IL 60523
DUPAGE
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
348,167
Income Statement
274,201
0
622,368
456,940
5,220
160,208
622,368 -195.8%
25.9%
16.0
357.1
5.0%
23.3%
Key Performanace Ind.
0.8
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 1,838,103
100.0%
133.5%
-33.5%
16.4%
0.0%
-17.1%
Current Assets
Fixed Assets
1,838,103
2,453,091
-614,988
301,344
0
(313,644)
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 113
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142818
O'FALLON DIALYSIS
1941 FRANK SCOTT PKWY E, SUITE B
SHILOH, IL 62269
SAINT CLAIR
DUMMY FOR MEDICAID HHA
12/31/2017 138 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
15,429
Income Statement
-57,867
0
-42,438
2,000
874
-45,312
-42,438 100.0%
848.6%
0.6
43.9
4.5%
33.2%
Key Performanace Ind.
7.7
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
1.5%6,124Contract Allowance
Total Charges 400,719
98.5%
111.5%
-11.5%
0.0%
0.0%
-11.5%
Current Assets
Fixed Assets
394,595
439,906
-45,311
0
0
(45,311)
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142674
OLNEY DIALYSIS CENTER
117 N BOONE
OLNEY, IL 62450
RICHLAND
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
932,399
Income Statement
800,340
1,056,029
2,788,768
27,978
0
2,760,790
2,788,768 9.6%
6.4%
6.8
60.4
6.0%
33.5%
Key Performanace Ind.
33.3
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-57.9%-474,266Contract Allowance
Total Charges 818,836
157.9%
79.5%
20.5%
0.0%
0.0%
20.5%
Current Assets
Fixed Assets
1,293,102
1,028,127
264,975
71
0
265,046
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 114
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142732
PALOS PARK DIALYSIS
13155 S LA GRANGE RD
ORLAND PARK, IL 60462
COOK
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
-616,406
Income Statement
380,045
0
-236,361
894,273
53,495
-1,184,127
-236,359 -21.7%
27.6%
3.6
113.8
5.1%
31.3%
Key Performanace Ind.
(0.7)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
3.8%102,062Contract Allowance
Total Charges 2,706,516
96.2%
90.2%
9.8%
0.1%
0.0%
9.9%
Current Assets
Fixed Assets
2,604,454
2,350,514
253,940
2,908
0
256,848
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142335
PRESENCE RESURRECTION MEDICAL CENTER
7435 W TALCOTT AVE
CHICAGO, IL 60631
COOK
DUMMY FOR MEDICAID HHA
Cost Report not filed.
Not for Profit
End Stage Renal Disease
Balance Sheet
0
Income Statement
0
0
0
0
0
0
0 0.0%
0.0%
0.0%
0.0%
Key Performanace Ind.
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 0
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Current Assets
Fixed Assets
0
0
0
0
0
0
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 115
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142318
PROVENA-ST MARYS HOSPITAL RENAL DIALYS
455 WEST COURT STREET
KANKAKEE, IL 60901
KANKAKEE
NATIONAL GOVERNMENT SERVICES
Cost Report not filed.
Not for Profit
End Stage Renal Disease
Balance Sheet
0
Income Statement
0
0
0
0
0
0
0 0.0%
0.0%
0.0%
0.0%
Key Performanace Ind.
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 0
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Current Assets
Fixed Assets
0
0
0
0
0
0
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142680
QUINCY MEDICAL GROUP
1025 MAINE STREET
QUINCY, IL 62301
ADAMS
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
31,757,101
Income Statement
32,398,964
1,121,291
65,277,356
16,498,195
33,027,471
15,751,690
65,277,356 5.5%
0.0%
1,915.8
312.5
4.3%
14.7%
Key Performanace Ind.
1.9
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
59.6%3,445,284Contract Allowance
Total Charges 5,776,238
40.4%
62.9%
37.1%
0.0%
0.0%
37.1%
Current Assets
Fixed Assets
2,330,954
1,466,601
864,353
0
0
864,353
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 116
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142637
RAI CARE CENTERS OF ILLINOIS I, LLC
160 NORTH MAIN STREET
BREESE, IL 62230
CLINTON
BLUE CROSS (GEORGIA)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
3,577,101
Income Statement
150,649
-1,718,600
2,009,150
-93,167
-360,733
-1,555,250
-2,009,150 -13.9%
13.8%
(30.5)
35.5
9.1%
37.4%
Key Performanace Ind.
(38.4)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 1,332,106
100.0%
83.8%
16.2%
0.0%
0.0%
16.2%
Current Assets
Fixed Assets
1,332,106
1,116,255
215,851
0
0
215,851
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142546
RAI CARE CENTERS OF ILLINOIS II LLC
1112 CENTRE WEST DR
SPRINGFIELD, IL 62704
SANGAMON
BLUE CROSS (TEXAS)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
18,576,211
Income Statement
515,816
-5,339,870
13,752,157
-339,982
-1,873,340
-11,538,837
-13,752,159 -24.1%
16.9%
(24.5)
111.5
7.0%
27.0%
Key Performanace Ind.
(54.6)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 7,833,936
100.0%
64.5%
35.5%
0.0%
0.0%
35.5%
Current Assets
Fixed Assets
7,833,936
5,055,797
2,778,139
0
0
2,778,139
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 117
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142652
RCG CENTRAL ILLINOIS-BLOOMINGTON CAPD
1404 EASTLAND DRIVE, SUITE 103
BLOOMINGTON, IL 61701
MCLEAN
NGS (IL)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
354,756
Income Statement
98,796
0
453,552
2,774,299
-735,455
-2,492,394
-453,550 -56.5%
17.7%
916.7
81.1
6.2%
31.9%
Key Performanace Ind.
0.1
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 2,512,029
100.0%
44.0%
56.0%
0.0%
0.0%
56.0%
Current Assets
Fixed Assets
2,512,029
1,104,691
1,407,338
0
0
1,407,338
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142562
RCG CENTRAL ILLINOIS - EAST PEORIA
3300 N MAIN STREET
EAST PEORIA, IL 61611
TAZEWELL
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
40,383,236
Income Statement
255,346
0
40,638,582
-351,935
-1,487,210
-38,799,437
-40,638,582 -5.6%
55.0%
(21.7)
86.2
6.4%
26.8%
Key Performanace Ind.
(114.7)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 8,089,530
100.0%
73.0%
27.0%
0.0%
0.0%
27.0%
Current Assets
Fixed Assets
8,089,530
5,908,706
2,180,824
-1
0
2,180,823
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 118
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142613
RCG CENTRAL ILLINOIS - PEORIA NORTH
10405 N JULIET COURT
PEORIA, IL 61615
PEORIA
CGS (KENTUCKY)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
23,028,136
Income Statement
479,548
7,429
23,515,113
-284,573
-1,733,128
-21,497,410
-23,515,111 -12.7%
18.9%
(21.9)
82.9
6.6%
29.9%
Key Performanace Ind.
(80.9)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 7,456,588
100.0%
63.5%
36.5%
0.0%
0.0%
36.5%
Current Assets
Fixed Assets
7,456,588
4,736,366
2,720,222
-1
0
2,720,221
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142610
RCG CENTRAL ILLINOIS DECATUR HOME DIALYSIS
302 WEST HAY ST SUITE 207
DECATUR, IL 62526
MACON
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
4,453,225
Income Statement
7,182
0
4,460,407
-31,804
-477,387
-3,951,216
-4,460,407 -13.4%
122.7%
(25.6)
42.7
8.7%
36.2%
Key Performanace Ind.
(140.0)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 981,036
100.0%
46.2%
53.8%
0.0%
0.0%
53.8%
Current Assets
Fixed Assets
981,036
452,803
528,233
1
0
528,234
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 119
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142538
RCG MIDAMERICA CRESTWOOD
4861 73 WEST CAL SAG ROAD
CRESTWOOD, IL 60445
COOK
BLUE CROSS (TEXAS)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
-152,391,386
Income Statement
328,605
0
-152,062,781
-315,031
-1,031,394
153,409,204
152,062,779 0.6%
21.6%
(31.8)
89.5
8.9%
36.5%
Key Performanace Ind.
483.7
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 4,610,719
100.0%
78.5%
21.5%
0.0%
0.0%
21.5%
Current Assets
Fixed Assets
4,610,719
3,617,583
993,136
-1
0
993,135
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142621
RCG MIDAMERICA EVANSTON
2953 CENTRAL ST 1ST FL
EVANSTON, IL 60201
COOK
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
3,750,970
Income Statement
557,296
9,425
4,317,691
-183,043
-645,827
-3,488,823
-4,317,693 -17.2%
19.3%
(26.1)
81.8
8.0%
34.4%
Key Performanace Ind.
(20.5)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 3,161,748
100.0%
81.0%
19.0%
0.0%
0.0%
19.0%
Current Assets
Fixed Assets
3,161,748
2,560,855
600,893
0
0
600,893
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 120
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142550
RCG MIDAMERICA ORLAND PARK
9160 WEST 159TH STREET
ORLAND PARK, IL 60462
COOK
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
-12,918,850
Income Statement
222,662
14,500
-12,681,688
-121,407
-709,287
13,512,381
12,681,687 5.3%
24.6%
(18.8)
98.1
9.9%
33.1%
Key Performanace Ind.
106.4
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 3,077,897
100.0%
76.6%
23.4%
0.0%
0.0%
23.4%
Current Assets
Fixed Assets
3,077,897
2,356,547
721,350
-2
0
721,348
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142522
RCG MIDAMERICA ROGERS PARK
2277 WEST HOWARD
CHICAGO, IL 60645
COOK
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
-126,629,573
Income Statement
775,943
0
-125,853,630
-443,801
-2,938,309
129,235,741
125,853,631 1.4%
22.0%
(57.7)
104.4
9.4%
37.0%
Key Performanace Ind.
285.3
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 4,567,968
100.0%
61.4%
38.6%
0.0%
0.0%
38.6%
Current Assets
Fixed Assets
4,567,968
2,805,439
1,762,529
0
0
1,762,529
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 121
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142618
RCG MIDAMERICA SKOKIE
9801 WOODS DRIVE
SKOKIE, IL 60076
COOK
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
7,484,473
Income Statement
675,614
8,942
8,169,029
-324,367
-1,095,020
-6,749,642
-8,169,029 -8.3%
10.7%
(37.0)
98.8
9.2%
35.0%
Key Performanace Ind.
(23.1)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 3,759,246
100.0%
85.1%
14.9%
0.0%
0.0%
14.9%
Current Assets
Fixed Assets
3,759,246
3,197,470
561,776
-1
0
561,775
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142597
RCG NORTHWESTERN OLSON PAV
710 N FAIRBANKS STE 4-200
CHICAGO, IL 60611
COOK
NGS (IL)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
44,131,412
Income Statement
499,529
6,162,931
50,793,872
-587,282
-2,216,478
-47,990,111
-50,793,871 -3.8%
23.8%
(38.3)
107.6
9.9%
33.4%
Key Performanace Ind.
(75.1)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 7,399,933
100.0%
75.5%
24.5%
0.0%
0.0%
24.5%
Current Assets
Fixed Assets
7,399,933
5,589,655
1,810,278
-3
0
1,810,275
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 122
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142772
RED BUD DIALYSIS
1500 E MARKET ST
RED BUD, IL 62278
RANDOLPH
DUMMY FOR MEDICAID HHA
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
-1,692,000
Income Statement
1,595,993
0
-96,007
29,978
1,008,068
-1,134,055
-96,009 23.1%
6.7%
3.3
71.8
3.8%
30.2%
Key Performanace Ind.
(56.4)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
2.2%16,835Contract Allowance
Total Charges 770,132
97.8%
134.8%
-34.8%
0.0%
0.0%
-34.8%
Current Assets
Fixed Assets
753,297
1,015,779
-262,482
15
0
(262,467)
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142742
RENAL CARE CENTER WEST JOLIET
1051 ESSINGTON ROAD
JOLIET, IL 60435
WILL
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
-7,937,978
Income Statement
668,197
18,089,799
10,820,018
1,747,078
35,941
9,036,999
10,820,018 20.8%
19.1%
6.9
116.6
6.3%
34.5%
Key Performanace Ind.
(4.5)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
6.3%456,572Contract Allowance
Total Charges 7,259,426
93.7%
72.6%
27.4%
0.2%
0.0%
27.6%
Current Assets
Fixed Assets
6,802,854
4,937,679
1,865,175
11,914
0
1,877,089
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 123
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142667
RENAL CARE GROUP
11630 SOUTH KEDZIE AVE
MERRIONETTE PARK, IL 60803
COOK
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
31,128,430
Income Statement
253,928
4,350
31,386,708
-1,704,905
-3,021,263
-26,660,540
-31,386,708 -15.6%
9.1%
(126.8)
51.9
10.8%
38.0%
Key Performanace Ind.
(18.3)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 9,077,901
100.0%
54.1%
45.9%
0.0%
0.0%
45.9%
Current Assets
Fixed Assets
9,077,901
4,908,212
4,169,689
1
0
4,169,690
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142517
RENAL CARE GROUP SOUTH SUBURBAN
2609 W LINCOLN HIGHWAY
OLYMPIA FIELDS, IL 60461
COOK
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
-157,528,590
Income Statement
468,059
4,561
-157,055,970
-527,391
-1,964,896
159,548,257
157,055,970 1.4%
28.7%
(38.4)
130.5
10.4%
33.4%
Key Performanace Ind.
298.7
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 7,223,882
100.0%
69.5%
30.5%
0.0%
0.0%
30.5%
Current Assets
Fixed Assets
7,223,882
5,018,078
2,205,804
-1
0
2,205,803
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 124
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142796
RENAL CARE PROVIDERS, LLC
2038 W 95TH STREET
CHICAGO, IL 60643
COOK
NGS (IL)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
1,380,390
Income Statement
21,637
0
1,402,027
1,880,679
0
-478,652
1,402,027 26.5%
269.6%
310.8
310.4
2.2%
26.2%
Key Performanace Ind.
0.7
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
78.7%5,947,424Contract Allowance
Total Charges 7,556,697
21.3%
107.9%
-7.9%
0.0%
0.0%
-7.9%
Current Assets
Fixed Assets
1,609,273
1,736,323
-127,050
0
0
(127,050)
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142741
RENAL CENTER NEW LENOX
1890 SILVER CROSS BLVD SUITE 150
NEW LENOX, IL 60451
WILL
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
-3,910,588
Income Statement
931,146
6,965,428
3,985,986
568,335
56,054
3,361,597
3,985,986 37.8%
19.0%
10.6
171.5
5.3%
32.1%
Key Performanace Ind.
(6.9)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-15.8%-695,972Contract Allowance
Total Charges 4,414,412
115.8%
75.3%
24.7%
0.2%
0.0%
24.9%
Current Assets
Fixed Assets
5,110,384
3,847,721
1,262,663
9,607
0
1,272,270
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 125
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142570
RENAL LIFE LINK INC
324 S 4TH ST
MARION, IL 62959
WILLIAMSON
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
12,492,597
Income Statement
205,780
0
12,698,377
134,001
5,244
12,559,130
12,698,375 25.3%
10.5%
3.7
48.7
4.7%
29.3%
Key Performanace Ind.
93.2
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-151.5%-3,360,355Contract Allowance
Total Charges 2,218,480
251.5%
43.1%
56.9%
0.1%
0.0%
57.0%
Current Assets
Fixed Assets
5,578,835
2,404,814
3,174,021
3,228
0
3,177,249
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142608
RENAL LIFE LINK INC
1151 ROUTE 14W
BENTON, IL 62812
FRANKLIN
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
-8,485,354
Income Statement
82,464
11,938,440
3,535,550
133,083
2,767
3,399,701
3,535,551 32.7%
5.6%
7.7
42.8
3.9%
30.7%
Key Performanace Ind.
(63.8)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-67.3%-1,103,862Contract Allowance
Total Charges 1,640,908
167.3%
59.8%
40.2%
0.3%
0.0%
40.5%
Current Assets
Fixed Assets
2,744,770
1,641,220
1,103,550
9,353
0
1,112,903
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 126
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142609
RENAL LIFE LINK INC
1231 ILLINOIS STATE ROUTE 161
CENTRALIA, IL 62801
MARION
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
8,750,089
Income Statement
316,457
0
9,066,546
746,957
3,001
8,316,588
9,066,546 21.7%
11.7%
5.9
126.8
5.3%
28.4%
Key Performanace Ind.
11.7
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-111.3%-2,381,423Contract Allowance
Total Charges 2,139,896
211.3%
60.7%
39.3%
0.6%
0.0%
39.9%
Current Assets
Fixed Assets
4,521,319
2,745,449
1,775,870
27,848
0
1,803,718
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142661
RENAL LIFE LINK, INC
6246 W 95TH ST
OAK LAWN, IL 60453
COOK
NGS (IL)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
9,156,981
Income Statement
1,361,139
2,556,911
13,075,031
955,961
238,387
11,880,681
13,075,029 4.2%
22.0%
5.8
120.3
4.8%
29.1%
Key Performanace Ind.
9.6
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.2%7,127Contract Allowance
Total Charges 3,659,197
99.8%
86.7%
13.3%
0.2%
0.0%
13.5%
Current Assets
Fixed Assets
3,652,070
3,164,801
487,269
7,331
0
494,600
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 127
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142634
RENAL TREATMENT CTR DBA MARYVILLE DIALYSIS
2102 VADALABENE DRIVE, SUITE 1
MARYVILLE, IL 62062
MADISON
BLUE CROSS (TEXAS)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
10,424,008
Income Statement
1,313,615
1,000
11,738,623
712,733
76,873
10,949,018
11,738,624 5.1%
11.8%
8.1
77.7
5.9%
29.3%
Key Performanace Ind.
14.6
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-0.1%-2,639Contract Allowance
Total Charges 3,203,237
100.1%
82.8%
17.2%
0.2%
0.0%
17.5%
Current Assets
Fixed Assets
3,205,876
2,653,611
552,265
7,539
0
559,804
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142648
RENAL TRMT CTR DBA WHITESIDE DIALYSIS
2600 N LOCUST
STERLING, IL 61081
WHITESIDE
NOVITAS (TEXAS)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
6,386,030
Income Statement
225,221
281,858
6,893,109
412,898
31,118
6,449,094
6,893,110 9.4%
20.5%
6.6
46.6
5.1%
34.0%
Key Performanace Ind.
15.5
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-22.6%-514,107Contract Allowance
Total Charges 2,275,307
122.6%
78.4%
21.6%
0.0%
0.0%
21.6%
Current Assets
Fixed Assets
2,789,414
2,186,501
602,913
966
0
603,879
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 128
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142803
RENVIVA, LLC
1235 N MULFORD RD
ROCKFORD, IL 61107
WINNEBAGO
DUMMY FOR MEDICAID HHA
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
270,073
Income Statement
109,825
0
379,898
1,818,342
0
-1,438,444
379,898 16.5%
18.4%
105.7
(170.5)
6.9%
36.1%
Key Performanace Ind.
0.1
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 507,219
100.0%
146.7%
-46.7%
0.0%
0.0%
-46.7%
Current Assets
Fixed Assets
507,219
744,104
-236,885
0
0
(236,885)
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142714
ROBINSON DIALYSIS LLC
1215 NORTH ALLEN STREET
ROBINSON, IL 62454
CRAWFORD
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
1,250,799
Income Statement
259,706
0
1,510,505
265,947
0
1,244,559
1,510,506 20.7%
12.4%
2.8
49.4
5.8%
32.3%
Key Performanace Ind.
4.7
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-0.6%-9,512Contract Allowance
Total Charges 1,550,066
100.6%
83.5%
16.5%
0.0%
0.0%
16.5%
Current Assets
Fixed Assets
1,559,578
1,302,313
257,265
211
0
257,476
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 129
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142670
ROSS DIALYSIS - ENGLEWOOD, LLC
6333 SOUTH GREEN ST
CHICAGO, IL 60621
COOK
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
1,990,781
Income Statement
193,714
0
2,184,495
-579,982
-663,184
-941,329
-2,184,495 -65.5%
23.3%
(82.7)
72.0
6.8%
36.3%
Key Performanace Ind.
(3.4)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 3,175,571
100.0%
80.6%
19.4%
0.0%
0.0%
19.4%
Current Assets
Fixed Assets
3,175,571
2,559,113
616,458
-2
0
616,456
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142665
ROXBURY DIALYSIS CENTER
622 ROXBURY ROAD
ROCKFORD, IL 61108
WINNEBAGO
BLUE CROSS (TEXAS)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
22,266,996
Income Statement
2,677,785
0
24,944,781
1,850,675
1,978,019
21,116,087
24,944,781 9.6%
6.3%
5.4
69.2
5.0%
26.6%
Key Performanace Ind.
12.0
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-20.4%-1,573,102Contract Allowance
Total Charges 7,724,264
120.4%
63.5%
36.5%
-14.6%
0.0%
21.9%
Current Assets
Fixed Assets
9,297,366
5,907,967
3,389,399
-1,353,993
0
2,035,406
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 130
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142642
RTC D/B/A FREEPORT DIALYSIS
1028 KUNKLE BLVD
FREEPORT, IL 61032
STEPHENSON
BLUE CROSS (TEXAS)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
4,128,060
Income Statement
91,402
0
4,219,462
21,472
28,102
4,169,887
4,219,461 6.0%
11.3%
3.2
48.3
4.8%
35.8%
Key Performanace Ind.
192.3
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-55.2%-566,992Contract Allowance
Total Charges 1,026,320
155.2%
84.2%
15.8%
0.0%
0.0%
15.8%
Current Assets
Fixed Assets
1,593,312
1,341,724
251,588
0
0
251,588
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142640
RTC DBA CHURCHVIEW DIALYSIS CENTER
417 WARE AVE
ROCKFORD, IL 61107
WINNEBAGO
BLUE CROSS (CALIFORNIA)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
35,856,752
Income Statement
1,556,079
18,593,317
56,006,148
1,405,636
98,875
54,501,638
56,006,149 8.4%
14.3%
3.8
131.7
4.5%
26.4%
Key Performanace Ind.
25.5
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-13.4%-1,233,230Contract Allowance
Total Charges 9,178,270
113.4%
56.2%
43.8%
0.3%
0.0%
44.1%
Current Assets
Fixed Assets
10,411,500
5,854,052
4,557,448
29,172
0
4,586,620
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 131
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142647
RTC DBA ROCKFORD DIALYSIS
3339 NORTH ROCKTON AVE
ROCKFORD, IL 61103
WINNEBAGO
BLUE CROSS (TEXAS)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
25,241,158
Income Statement
614,392
0
25,855,550
677,614
109,667
25,068,269
25,855,550 14.9%
14.3%
2.9
116.2
5.9%
26.8%
Key Performanace Ind.
37.3
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-76.5%-3,507,486Contract Allowance
Total Charges 4,584,035
176.5%
53.9%
46.1%
0.0%
0.0%
46.2%
Current Assets
Fixed Assets
8,091,521
4,358,007
3,733,514
1,696
0
3,735,210
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142312
RUSH PRES ST LUKES MEDICAL CEN
1653 WEST CONGRESS PARKWAY, 735 KELLOGG
CHICAGO, IL 60612
COOK
NATIONAL GOVERNMENT SERVICES
Cost Report not filed.
Not for Profit
End Stage Renal Disease
Balance Sheet
0
Income Statement
0
0
0
0
0
0
0 0.0%
0.0%
0.0%
0.0%
Key Performanace Ind.
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 0
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Current Assets
Fixed Assets
0
0
0
0
0
0
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 132
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142758
SAH DIALYSIS CENTER AT 26TH STREET
3059 W 26TH STREET
CHICAGO, IL 60623
COOK
DUMMY FOR MEDICAID HHA
6/30/2017 365 Days Settled
Not for Profit
End Stage Renal Disease
Balance Sheet
508,816
Income Statement
187,752
0
696,568
0
507,333
189,235
696,568 100.0%
0.0%
0.0
1,361.5
13.0%
37.8%
Key Performanace Ind.
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
88.1%10,359,215Contract Allowance
Total Charges 11,761,160
11.9%
86.5%
13.5%
0.0%
0.0%
13.5%
Current Assets
Fixed Assets
1,401,945
1,212,709
189,236
0
0
189,236
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142807
SALEM HOME TRAINING
1201 RICKER RD
SALEM, IL 62881
MARION
DUMMY FOR MEDICAID HHA
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
-189,247
Income Statement
166,269
0
-22,978
67,824
1,284
-92,086
-22,978 -240.3%
22.0%
4.6
186.5
2.0%
33.6%
Key Performanace Ind.
(2.8)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-63.0%-270,310Contract Allowance
Total Charges 429,060
163.0%
68.4%
31.6%
0.0%
0.0%
31.6%
Current Assets
Fixed Assets
699,370
478,104
221,266
0
0
221,266
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 133
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142746
SATELLITE DIALYSIS OF GLENVIEW
2601 COMPASS ROAD
GLENVIEW, IL 60026
COOK
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
720,676
Income Statement
316,193
0
1,036,869
5,030,812
0
-3,993,943
1,036,869 20.4%
19.1%
15.4
52.6
6.4%
26.1%
Key Performanace Ind.
0.1
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
1.4%33,119Contract Allowance
Total Charges 2,319,012
98.6%
135.7%
-35.7%
0.0%
0.0%
-35.6%
Current Assets
Fixed Assets
2,285,893
3,100,886
-814,993
426
0
(814,567)
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142561
SAUGET DIALYSIS
2061 GOOSE LAKE ROAD
EAST SAINT LOUIS, IL 62206
SAINT CLAIR
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
-37,072,497
Income Statement
880,656
241,507
-35,950,334
111,387
0
-36,061,723
-35,950,336 -1.3%
8.7%
2.8
152.3
8.1%
30.5%
Key Performanace Ind.
(332.8)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-1.4%-52,080Contract Allowance
Total Charges 3,655,716
101.4%
87.9%
12.1%
0.2%
0.0%
12.3%
Current Assets
Fixed Assets
3,707,796
3,259,868
447,928
7,431
0
455,359
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 134
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142654
SCHAUMBURG RENAL CENTER
1156 ROSELLE RD
SCHAUMBURG, IL 60193
COOK
BLUE CROSS (FLORIDA)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
4,927,680
Income Statement
581,871
1,903,379
7,412,930
689,222
7,921
6,715,785
7,412,928 7.6%
12.1%
7.1
103.9
5.6%
34.6%
Key Performanace Ind.
7.1
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-0.9%-35,502Contract Allowance
Total Charges 4,072,732
100.9%
87.6%
12.4%
0.0%
0.0%
12.4%
Current Assets
Fixed Assets
4,108,234
3,599,382
508,852
1,060
0
509,912
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142624
SHELBYVILLE COMMUNITY DIALYSIS
410 SOUTH HEILEIN DRIVE
SHELBYVILLE, IL 62565
SHELBY
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
62,591
Income Statement
94,247
3,471,709
3,628,547
102,838
0
3,525,709
3,628,547 -3.2%
7.3%
10.0
3.3
4.2%
30.1%
Key Performanace Ind.
0.6
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 1,438,825
100.0%
107.9%
-7.9%
0.0%
0.0%
-7.9%
Current Assets
Fixed Assets
1,438,825
1,552,195
-113,370
0
0
(113,370)
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 135
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142816
SHIFA DIALYSIS
1540 W CHICAGO AVE
CHICAGO, IL 60642
COOK
NATIONAL GOVERNMENT SERVICES
12/31/2017 203 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
255,031
Income Statement
154,262
0
409,293
500,219
0
-90,926
409,293 100.0%
21.6%
0.0
14.8
0.0%
44.2%
Key Performanace Ind.
0.5
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 237,722
100.0%
138.2%
-38.2%
0.0%
0.0%
-38.2%
Current Assets
Fixed Assets
237,722
328,648
-90,926
0
0
(90,926)
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142757
SILVERBRIDGE HOME TRAINING
2410 ALFT LANE, SUITE 101
ELGIN, IL 60124
KANE
DUMMY FOR MEDICAID HHA
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
323,856
Income Statement
354,068
0
677,924
448,867
20,363
208,694
677,924 233.8%
12.7%
8.6
433.9
3.3%
22.4%
Key Performanace Ind.
0.7
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
27.5%585,500Contract Allowance
Total Charges 2,128,414
72.5%
68.4%
31.6%
0.0%
0.0%
31.6%
Current Assets
Fixed Assets
1,542,914
1,055,091
487,823
191
0
488,014
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 136
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142560
SKYLINE HOME DIALYSIS
7009 BELMONT AVENUE
CHICAGO, IL 60634
COOK
DUMMY FOR MEDICAID HHA
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
23,640,937
Income Statement
3,351
23,305
23,667,593
1,493,575
0
22,174,017
23,667,592 5.2%
8.2%
3.0
242.2
3.1%
24.0%
Key Performanace Ind.
15.8
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-9.3%-206,044Contract Allowance
Total Charges 2,224,187
109.3%
52.8%
47.2%
0.2%
0.0%
47.4%
Current Assets
Fixed Assets
2,430,231
1,283,073
1,147,158
3,649
0
1,150,807
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142662
SOUTH BARRINGTON DIALYSIS CENTER
33 W HIGGINS ROAD SUITE 920 945
SOUTH BARRINGTON, IL 60010
LAKE
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
1,587,053
Income Statement
117,487
25,049
1,729,589
1,429,351
0
300,239
1,729,590 1,538.0%
14.0%
29.1
70.5
11.7%
33.4%
Key Performanace Ind.
1.1
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-38.2%-1,906,209Contract Allowance
Total Charges 4,996,200
138.2%
33.1%
66.9%
0.0%
0.0%
66.9%
Current Assets
Fixed Assets
6,902,409
2,284,710
4,617,699
0
0
4,617,699
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 137
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142508
SOUTHSIDE DIALYSIS CENTER
3134 W 76TH STREET
CHICAGO, IL 60652
COOK
BLUE CROSS (TEXAS)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
18,573,246
Income Statement
468,235
0
19,041,481
-918,230
-3,650,896
-14,472,356
-19,041,482 -22.7%
20.9%
(55.4)
111.8
9.1%
40.1%
Key Performanace Ind.
(20.2)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 9,341,761
100.0%
64.8%
35.2%
0.0%
0.0%
35.2%
Current Assets
Fixed Assets
9,341,761
6,052,697
3,289,064
-1
0
3,289,063
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142586
SPRINGFIELD CENTRAL DIALYSIS
932 N RUTLEDGE ST
SPRINGFIELD, IL 62781
SANGAMON
BLUE CROSS (GEORGIA)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
17,969,339
Income Statement
45,967
8,075,084
26,090,390
603,961
82,936
25,403,493
26,090,390 8.4%
13.3%
4.2
162.2
4.7%
29.8%
Key Performanace Ind.
29.8
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-143.7%-2,932,608Contract Allowance
Total Charges 2,041,121
243.7%
59.8%
40.2%
2.5%
0.0%
42.8%
Current Assets
Fixed Assets
4,973,729
2,972,012
2,001,717
126,500
0
2,128,217
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 138
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142590
SPRINGFIELD MONTVALE DIALYSIS
2930 MONTVALE DRIVE SUITE A
SPRINGFIELD, IL 62704
SANGAMON
BLUE CROSS (GEORGIA)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
16,379,742
Income Statement
141,322
0
16,521,064
739,953
5,148
15,775,963
16,521,064 6.5%
11.7%
4.4
142.7
6.5%
33.4%
Key Performanace Ind.
22.1
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-0.5%-15,859Contract Allowance
Total Charges 3,427,474
100.5%
70.4%
29.6%
0.2%
0.0%
29.8%
Current Assets
Fixed Assets
3,443,333
2,423,511
1,019,822
7,300
0
1,027,122
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142733
SPRINGFIELD SOUTH DIALYSIS
2930 S 6TH ST
SPRINGFIELD, IL 62703
SANGAMON
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
3,655,249
Income Statement
540,378
0
4,195,627
407,471
21,099
3,767,058
4,195,628 42.5%
12.3%
3.7
133.9
4.1%
26.4%
Key Performanace Ind.
9.0
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-5.1%-235,899Contract Allowance
Total Charges 4,667,258
105.1%
68.0%
32.0%
0.7%
0.0%
32.7%
Current Assets
Fixed Assets
4,903,157
3,334,083
1,569,074
32,767
0
1,601,841
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 139
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142615
STONECREST DIALYSIS
1302 EAST STATE STREET
ROCKFORD, IL 61104
WINNEBAGO
CGS (KENTUCKY)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
1,932,140
Income Statement
301,846
0
2,233,986
243,162
46,876
1,943,948
2,233,986 23.3%
25.2%
6.0
103.9
4.9%
28.8%
Key Performanace Ind.
7.9
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-3.3%-97,981Contract Allowance
Total Charges 2,930,922
103.3%
85.2%
14.8%
0.2%
0.0%
15.0%
Current Assets
Fixed Assets
3,028,903
2,580,504
448,399
4,860
0
453,259
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142553
SUN HEALTH INC
2121 ONEIDA ST SUITE 104
JOLIET, IL 60435
WILL
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
3,569,756
Income Statement
154,954
0
3,724,710
430,771
0
3,293,939
3,724,710 6.2%
9.4%
53.4
151.0
7.4%
38.3%
Key Performanace Ind.
8.3
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
18.7%608,496Contract Allowance
Total Charges 3,251,512
81.3%
92.3%
7.7%
0.0%
0.0%
7.7%
Current Assets
Fixed Assets
2,643,016
2,440,730
202,286
763
0
203,049
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 140
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142639
SYCAMORE DIALYSIS
2200 GATEWAY DRIVE
SYCAMORE, IL 60178
DEKALB
BLUE CROSS (TEXAS)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
-25,632,379
Income Statement
280,503
112,612
-25,239,264
159,328
24,714
-25,423,306
-25,239,264 -0.4%
14.0%
5.8
92.4
4.4%
28.3%
Key Performanace Ind.
(160.9)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-6.5%-183,229Contract Allowance
Total Charges 2,829,426
106.5%
81.5%
18.5%
-15.4%
0.0%
3.1%
Current Assets
Fixed Assets
3,012,655
2,455,252
557,403
-464,595
0
92,808
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142767
TAZEWELL COUNTY DIALYSIS
1021 COURT ST, SUITE A
PEKIN, IL 61554
TAZEWELL
DUMMY FOR MEDICAID HHA
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
459,497
Income Statement
946,108
0
1,405,605
57,814
47,016
1,300,775
1,405,605 -17.9%
10.4%
4.0
184.8
3.1%
29.0%
Key Performanace Ind.
7.9
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-4.6%-63,082Contract Allowance
Total Charges 1,374,718
104.6%
117.9%
-17.9%
1.7%
0.0%
-16.2%
Current Assets
Fixed Assets
1,437,800
1,694,888
-257,088
24,816
0
(232,272)
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 141
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142763
TIMBER CREEK DIALYSIS
1001 S ANNIE GLIDDEN RD
DEKALB, IL 60115
DEKALB
DUMMY FOR MEDICAID HHA
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
1,243,808
Income Statement
768,112
0
2,011,920
228,367
46,501
1,737,052
2,011,920 -6.4%
14.4%
2.5
78.1
4.1%
28.1%
Key Performanace Ind.
5.4
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-7.1%-75,002Contract Allowance
Total Charges 1,058,753
107.1%
116.2%
-16.2%
6.4%
0.0%
-9.8%
Current Assets
Fixed Assets
1,133,755
1,317,456
-183,701
73,090
0
(110,611)
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142810
TINLEY PARK DIALYSIS
16767 80TH AVE
TINLEY PARK, IL 60477
COOK
DUMMY FOR MEDICAID HHA
12/31/2017 381 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
942,491
Income Statement
3,828,924
0
4,771,415
333,300
2,614,712
1,823,404
4,771,416 -30.1%
10.1%
1.3
147.1
2.0%
22.3%
Key Performanace Ind.
2.8
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-7.3%-43,673Contract Allowance
Total Charges 597,589
107.3%
208.0%
-108.0%
22.5%
0.0%
-85.5%
Current Assets
Fixed Assets
641,262
1,333,907
-692,645
144,316
0
(548,329)
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 142
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142649
TOTAL RENAL CARE D/B/A MONTCLARE DIALYSIS
7009 W BELMONT
CHICAGO, IL 60634
COOK
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
19,145,458
Income Statement
43,829
746,185
19,935,472
1,444,729
0
18,490,741
19,935,470 11.4%
9.7%
6.0
96.1
5.1%
32.1%
Key Performanace Ind.
13.3
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-9.2%-477,609Contract Allowance
Total Charges 5,199,871
109.2%
62.8%
37.2%
0.1%
0.0%
37.3%
Current Assets
Fixed Assets
5,677,480
3,564,618
2,112,862
3,528
0
2,116,390
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142604
TOTAL RENAL CARE DBA CHILDRENS DIALYSIS CTR
1333 N KINGSBURY ST, SUITE 100
CHICAGO, IL 60642
COOK
BLUE CROSS (CALIFORNIA)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
1,306,386
Income Statement
1,260,298
103,352
2,670,036
1,184,762
247,723
1,237,552
2,670,037 22.8%
13.6%
9.0
126.6
3.5%
43.0%
Key Performanace Ind.
1.1
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
2.6%91,725Contract Allowance
Total Charges 3,518,381
97.4%
91.8%
8.2%
0.0%
0.0%
8.2%
Current Assets
Fixed Assets
3,426,656
3,145,089
281,567
1,002
0
282,569
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 143
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142711
TOTAL RENAL CARE INC DBA ADAMS COUNTY DIALYSIS
436 NORTH 10TH STREET
QUINCY, IL 62301
ADAMS
NGS (IL)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
4,208,386
Income Statement
288,953
0
4,497,339
443,267
0
4,054,072
4,497,339 31.4%
21.3%
4.8
127.4
5.6%
30.3%
Key Performanace Ind.
9.5
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
1.4%55,741Contract Allowance
Total Charges 4,042,093
98.6%
68.5%
31.5%
0.4%
0.0%
31.9%
Current Assets
Fixed Assets
3,986,352
2,730,133
1,256,219
14,786
0
1,271,005
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142708
TOTAL RENAL CARE INC DBA PITTSFIELD DIALYSIS
640 WEST WASHINGTON STREET
PITTSFIELD, IL 62363
PIKE
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
-15,467
Income Statement
29,840
0
14,373
141,946
0
-127,573
14,373 -47.5%
7.8%
3.2
100.5
4.5%
44.0%
Key Performanace Ind.
(0.1)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-6.9%-47,666Contract Allowance
Total Charges 690,010
106.9%
92.5%
7.5%
0.7%
0.0%
8.2%
Current Assets
Fixed Assets
737,676
682,399
55,277
5,369
0
60,646
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 144
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142753
TOTAL RENAL CARE INC DBA SHILOH DIALYSIS
1095 N GREEN MOUNT RD
BELLEVILLE, IL 62221
SAINT CLAIR
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
1,299,042
Income Statement
758,444
0
2,057,486
495,597
88,458
1,473,431
2,057,486 36.2%
14.2%
2.5
121.7
5.0%
29.6%
Key Performanace Ind.
2.6
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
1.6%53,551Contract Allowance
Total Charges 3,313,118
98.4%
83.7%
16.3%
0.0%
0.0%
16.4%
Current Assets
Fixed Assets
3,259,567
2,727,183
532,384
1,080
0
533,464
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142552
TOTAL RENAL CARE LAKE COUNTY DIALYSIS CTR
565 LAKEVIEW PARKWAY SUITE 176
VERNON HILLS, IL 60061
LAKE
BLUE CROSS (CALIFORNIA)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
20,050,011
Income Statement
1,060,597
537,361
21,647,969
2,012,162
193,219
19,442,589
21,647,970 8.2%
13.3%
5.3
103.9
5.3%
37.4%
Key Performanace Ind.
10.0
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-12.7%-535,328Contract Allowance
Total Charges 4,207,253
112.7%
66.3%
33.7%
0.1%
0.0%
33.8%
Current Assets
Fixed Assets
4,742,581
3,145,514
1,597,067
5,165
0
1,602,232
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 145
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142534
TOTAL RENAL CARE LOGAN SQUARE DIALYSIS SVS
2838 N KIMBALL AVE
CHICAGO, IL 60618
COOK
BLUE CROSS (CALIFORNIA)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
19,562,844
Income Statement
1,000,851
4,021,294
24,584,989
3,419,277
237,525
20,928,187
24,584,989 9.8%
19.3%
5.2
117.0
5.6%
29.8%
Key Performanace Ind.
5.7
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-10.1%-749,244Contract Allowance
Total Charges 7,418,312
110.1%
75.2%
24.8%
0.3%
0.0%
25.1%
Current Assets
Fixed Assets
8,167,556
6,141,359
2,026,197
26,917
0
2,053,114
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142548
TOTAL RENAL CARE OLYMPIA FIELD
4557B W LINCOLN HIGHWAY
MATTESON, IL 60443
COOK
BLUE CROSS (CALIFORNIA)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
33,795,287
Income Statement
396,554
786,579
34,978,420
1,501,230
8,461
33,468,727
34,978,418 10.2%
10.2%
2.8
115.5
5.4%
27.4%
Key Performanace Ind.
22.5
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-18.3%-1,287,467Contract Allowance
Total Charges 7,038,890
118.3%
59.2%
40.8%
0.0%
0.0%
40.9%
Current Assets
Fixed Assets
8,326,357
4,926,785
3,399,572
3,035
0
3,402,607
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 146
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142719
TOTAL RENAL CARE WEST LAWN DIALYSIS
7000 SOUTH PULASKI ROAD
CHICAGO, IL 60629
COOK
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
4,322,331
Income Statement
308,372
0
4,630,703
1,507,401
18,757
3,104,544
4,630,702 28.7%
17.0%
11.9
119.1
4.8%
31.4%
Key Performanace Ind.
2.9
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-1.1%-40,369Contract Allowance
Total Charges 3,640,091
101.1%
75.9%
24.1%
0.1%
0.0%
24.2%
Current Assets
Fixed Assets
3,680,460
2,793,385
887,075
2,786
0
889,861
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142529
TOTAL RENAL CARE, INC
710 WEST 43RD ST
CHICAGO, IL 60609
COOK
BLUE CROSS (CALIFORNIA)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
13,147,357
Income Statement
525,402
1,061,668
14,734,427
563,516
6,916
14,163,996
14,734,428 10.0%
7.8%
3.1
184.0
5.1%
30.0%
Key Performanace Ind.
23.3
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-13.7%-705,418Contract Allowance
Total Charges 5,144,176
113.7%
76.0%
24.0%
0.1%
0.0%
24.1%
Current Assets
Fixed Assets
5,849,594
4,446,078
1,403,516
6,208
0
1,409,724
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 147
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142718
TOTAL RENAL CARE, INC
8725 SOUTH STONY ISLAND AVENUE
CHICAGO, IL 60617
COOK
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
-1,423,303
Income Statement
2,372,633
9,369,003
10,318,333
926,259
414,692
8,977,382
10,318,333 7.3%
13.3%
(15.3)
128.8
5.5%
29.0%
Key Performanace Ind.
(1.5)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
3.2%235,080Contract Allowance
Total Charges 7,273,803
96.8%
90.7%
9.3%
0.0%
0.0%
9.3%
Current Assets
Fixed Assets
7,038,723
6,384,308
654,415
2,892
0
657,307
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142614
TRI CITIES DIALYSIS
306 RANDALL ROAD
GENEVA, IL 60134
KANE
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
2,186,127
Income Statement
66,560
0
2,252,687
137,681
0
2,115,006
2,252,687 19.4%
19.4%
11.3
382.2
6.1%
28.0%
Key Performanace Ind.
15.9
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 3,489,500
100.0%
88.2%
11.8%
0.0%
0.0%
11.8%
Current Assets
Fixed Assets
3,489,500
3,078,140
411,360
0
0
411,360
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 148
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142316
UNIVERSITY OF ILLINOIS HOSPITA
1859 W TAYLOR, MC 794
CHICAGO, IL 60612
COOK
NATIONAL GOVERNMENT SERVICES
Cost Report not filed.
For Profit
End Stage Renal Disease
Balance Sheet
0
Income Statement
0
0
0
0
0
0
0 0.0%
0.0%
0.0%
0.0%
Key Performanace Ind.
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 0
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Current Assets
Fixed Assets
0
0
0
0
0
0
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142749
US RENAL CARE BOLINGBROOK DIALYSIS
396 REMINGTON BLVD, STE 140
BOLINGBROOK, IL 60440
WILL
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
2,870,848
Income Statement
550,665
2,823
3,424,336
3,026,261
177,576
220,499
3,424,336 151.4%
19.2%
12.7
317.3
4.5%
29.0%
Key Performanace Ind.
0.9
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
97.1%95,851,253Contract Allowance
Total Charges 98,696,481
2.9%
88.3%
11.7%
0.0%
0.0%
11.7%
Current Assets
Fixed Assets
2,845,228
2,511,387
333,841
0
0
333,841
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 149
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142750
US RENAL CARE OAK BROOK DIALYSIS
1201-B BUTTERFIELD RD
DOWNERS GROVE, IL 60515
DUPAGE
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
1,383,846
Income Statement
722,496
10,241
2,116,583
1,229,555
167,997
719,031
2,116,583 29.6%
14.8%
17.9
96.0
4.5%
31.2%
Key Performanace Ind.
1.1
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
97.6%89,891,486Contract Allowance
Total Charges 92,139,300
2.4%
90.5%
9.5%
0.0%
0.0%
9.5%
Current Assets
Fixed Assets
2,247,814
2,035,325
212,489
0
0
212,489
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142787
US RENAL CARE VILLA PARK HOME DIALYSIS PROGRAM
202 E NORTH AVENUE
VILLA PARK, IL 60181
DUPAGE
NGS (IL)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
522,527
Income Statement
368,928
0
891,455
-272,805
41,970
1,122,290
891,455 30.7%
19.5%
6.6
141.1
0.4%
11.2%
Key Performanace Ind.
(1.9)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
89.9%10,859,704Contract Allowance
Total Charges 12,076,171
10.1%
71.7%
28.3%
0.0%
0.0%
28.3%
Current Assets
Fixed Assets
1,216,467
872,481
343,986
0
0
343,986
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 150
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142751
USRC ADVANCED HOME THERAPIES, LLC
1201 BUTTERFIELD RD
DOWNERS GROVE, IL 60515
DUPAGE
NGS (IL)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
1,784,135
Income Statement
11,255
2,460,945
4,256,335
2,079,858
-28,076
2,204,553
4,256,335 -0.1%
28.6%
20.4
900.9
2.1%
25.6%
Key Performanace Ind.
0.9
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
96.3%17,600,857Contract Allowance
Total Charges 18,272,188
3.7%
100.2%
-0.2%
0.0%
0.0%
-0.2%
Current Assets
Fixed Assets
671,331
672,614
-1,283
0
0
(1,283)
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142755
USRC RENAL CARE VILLA PARK DIALYSIS
200 E NORTH AVENUE
VILLA PARK, IL 60181
DUPAGE
DUMMY FOR MEDICAID HHA
6/30/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
2,248,395
Income Statement
925,149
-783
3,172,761
2,572,524
56,629
543,608
3,172,761 147.2%
13.7%
12.2
199.3
3.5%
27.8%
Key Performanace Ind.
0.9
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
96.4%92,552,564Contract Allowance
Total Charges 96,006,388
3.6%
76.8%
23.2%
0.0%
0.0%
23.2%
Current Assets
Fixed Assets
3,453,824
2,653,402
800,422
0
0
800,422
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 151
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142738
USRC STREAMWOOD, LLC
149 E IRVING PARK ROAD
STREAMWOOD, IL 60107
COOK
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
2,106,555
Income Statement
456,241
0
2,562,796
1,851,909
129,011
581,876
2,562,796 70.9%
15.2%
11.9
257.2
3.9%
25.6%
Key Performanace Ind.
1.1
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
96.4%68,500,622Contract Allowance
Total Charges 71,081,479
3.6%
84.0%
16.0%
0.0%
0.0%
16.0%
Current Assets
Fixed Assets
2,580,857
2,168,253
412,604
0
0
412,604
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142693
VANDALIA DIALYSIS
301 MATTES AVE
VANDALIA, IL 62471
FAYETTE
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
901,173
Income Statement
105,331
0
1,006,504
13,970
2,870
989,665
1,006,505 -3.2%
10.0%
2.6
55.5
4.6%
33.2%
Key Performanace Ind.
64.5
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-1.2%-12,036Contract Allowance
Total Charges 1,006,919
101.2%
103.1%
-3.1%
0.0%
0.0%
-3.1%
Current Assets
Fixed Assets
1,018,955
1,050,161
-31,206
11
0
(31,195)
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 152
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142812
VERMILION COUNTY DIALYSIS
26 EAST WEST NEWELL RD
DANVILLE, IL 61834
VERMILION
NATIONAL GOVERNMENT SERVICES
12/31/2017 319 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
224,219
Income Statement
-336,854
0
-112,635
12,488
9,186
-134,308
-112,634 100.0%
-109.7%
1.1
436.0
3.9%
29.9%
Key Performanace Ind.
18.0
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
1.7%16,383Contract Allowance
Total Charges 951,213
98.3%
114.4%
-14.4%
0.0%
0.0%
-14.4%
Current Assets
Fixed Assets
934,830
1,069,163
-134,333
22
0
(134,311)
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142743
VILLA PARK HOME DIALYSIS
1634 S ARDMORE AVE
VILLA PARK, IL 60181
DUPAGE
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
73,624
Income Statement
0
0
73,624
192,000
0
-118,376
73,624 -0.9%
3,188.2%
0.0
60.6
3.2%
35.7%
Key Performanace Ind.
0.4
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 353,347
100.0%
99.7%
0.3%
0.0%
0.0%
0.3%
Current Assets
Fixed Assets
353,347
352,248
1,099
0
0
1,099
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 153
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142688
WAYNE COUNTY DIALYSIS
303 NW 11TH STREET
FAIRFIELD, IL 62837
WAYNE
PALMETTO (CALIFORNIA)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
3,545,990
Income Statement
69,633
0
3,615,623
374,618
0
3,241,005
3,615,623 19.4%
7.4%
4.5
55.6
4.4%
30.5%
Key Performanace Ind.
9.5
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-16.7%-254,610Contract Allowance
Total Charges 1,520,353
116.7%
64.5%
35.5%
0.0%
0.0%
35.5%
Current Assets
Fixed Assets
1,774,963
1,145,425
629,538
71
0
629,609
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142687
WELLBOUND OF EVANSTON, LLC
8950 GROSS POINT ROAD, SUITE 300
SKOKIE, IL 60077
COOK
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
Not for Profit
End Stage Renal Disease
Balance Sheet
1,366,413
Income Statement
64,599
0
1,431,012
1,006,837
0
424,175
1,431,012 78.3%
17.8%
20.6
38.0
3.1%
20.9%
Key Performanace Ind.
1.4
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
2.7%95,303Contract Allowance
Total Charges 3,549,915
97.3%
90.4%
9.6%
0.0%
0.0%
9.6%
Current Assets
Fixed Assets
3,454,612
3,122,550
332,062
72
0
332,134
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 154
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142536
WEST METRO DIALYSIS - HUMBOLT
1044 N MOZART
CHICAGO, IL 60622
COOK
BLUE CROSS (TEXAS)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
37,134,008
Income Statement
106,367
25,992
37,266,367
-1,002,680
-5,651,557
-30,612,129
-37,266,366 -17.3%
15.6%
(67.1)
95.2
10.3%
37.1%
Key Performanace Ind.
(37.0)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 10,755,774
100.0%
50.7%
49.3%
0.0%
0.0%
49.3%
Current Assets
Fixed Assets
10,755,774
5,454,418
5,301,356
0
0
5,301,356
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142783
WEST SIDE DIALYSIS
1600 W 13TH ST, SUITE 3
CHICAGO, IL 60608
COOK
DUMMY FOR MEDICAID HHA
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
-1,649,028
Income Statement
994,828
0
-654,200
425,346
94,851
-1,174,395
-654,198 38.3%
19.9%
7.7
227.1
4.5%
32.0%
Key Performanace Ind.
(3.9)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-11.0%-138,615Contract Allowance
Total Charges 1,262,497
111.0%
132.1%
-32.1%
0.0%
0.0%
-32.1%
Current Assets
Fixed Assets
1,401,112
1,851,299
-450,187
537
0
(449,650)
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 155
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142721
WOODLAWN DIALYSIS
5060 S STATE STREET
CHICAGO, IL 60609
COOK
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
497,971
Income Statement
1,224,540
2,330,000
4,052,511
1,128,643
109,806
2,814,064
4,052,513 18.0%
16.0%
4.6
207.5
5.6%
30.7%
Key Performanace Ind.
0.4
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.9%56,733Contract Allowance
Total Charges 6,127,924
99.1%
92.1%
7.9%
0.5%
0.0%
8.4%
Current Assets
Fixed Assets
6,071,191
5,592,849
478,342
28,630
0
506,972
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142696
WOODRIDGE HOME DIALYSIS
7425 JANES AVE
WOODRIDGE, IL 60517
DUPAGE
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
267,854
Income Statement
69,354
0
337,208
62,333
46,332
228,543
337,208 -60.7%
9.1%
1.4
50.0
3.2%
24.8%
Key Performanace Ind.
4.3
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
-0.7%-1,610Contract Allowance
Total Charges 245,380
100.7%
156.2%
-56.2%
0.1%
0.0%
-56.1%
Current Assets
Fixed Assets
246,990
385,800
-138,810
143
0
(138,667)
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 156
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142605
WSKC BOLINGBROOK DIALYSIS CTR
329 REMINGTON BLVD
BOLINGBROOK, IL 60440
WILL
BLUE CROSS (TEXAS)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
30,933,299
Income Statement
128,464
0
31,061,763
-374,761
-2,718,357
-27,968,646
-31,061,764 -10.5%
66.5%
(29.1)
106.3
10.7%
38.4%
Key Performanace Ind.
(82.5)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 7,654,963
100.0%
61.5%
38.5%
0.0%
0.0%
38.5%
Current Assets
Fixed Assets
7,654,963
4,704,332
2,950,631
-2
0
2,950,629
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
142601
WSKC GREENWOOD DIALYSIS CTR
1111 EAST 87TH STE 700
CHICAGO, IL 60619
COOK
BLUE SHIELD (TEXAS)
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
10,053,167
Income Statement
420,496
10,875
10,484,538
-615,594
-631,810
-9,237,135
-10,484,539 -15.9%
16.3%
(54.6)
94.2
9.4%
38.2%
Key Performanace Ind.
(16.3)
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 5,582,082
100.0%
73.8%
26.2%
0.0%
0.0%
26.2%
Current Assets
Fixed Assets
5,582,082
4,117,712
1,464,370
0
0
1,464,370
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 157
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.
142709
YORKVILLE DIALYSIS, LLC
1400 N BEECHER ROAD, LLC
YORKVILLE, IL 60560
KENDALL
NATIONAL GOVERNMENT SERVICES
12/31/2017 365 Days Settled
For Profit
End Stage Renal Disease
Balance Sheet
610,546
Income Statement
401,045
1,143
1,012,734
582,569
0
430,165
1,012,734 73.3%
6.3%
12.0
367.5
3.0%
24.1%
Key Performanace Ind.
1.0
Salary Expense
Fringe Benefits
Current Ratio
Days to Collect
Avg Payment Days
Depreciation Rate
Return on Equity
0.0%0Contract Allowance
Total Charges 1,235,600
100.0%
74.5%
25.5%
0.0%
0.0%
25.5%
Current Assets
Fixed Assets
1,235,600
920,805
314,795
598
0
315,393
Other Assets
Total Assets
Current Liabilities
Long Term Liabilities
Total Equity
Total Liab. and Equity
Operating Revenue
Operating Expense
Operating Margin
Other Income
Other Expense
Net Profit or Loss
All Providers
8:00 PM
2/9/2021 Page No 158
Healthcare Almanac 561-594-7551
www.halmanac.com
ESRD Profile Report - 2017Sample End Stage Renal Dialysis reports from the Halmanac.com website.